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Oral creatine supplementation has been shown to increase skeletal muscle total creatine 
(TCr) content, and in some cases improve performance in high-intensity short duration 
exercise. A variety of factors related to an enhanced efficacy of adenine nucleotide 
metabolism have been demonstrated as partly responsible for this ergogenic effect. Also, 
there is evidence that high-intensity sprint training results in a decrease in muscle total 
adenine nucleotide (TAN) and/or ATP stores. This placebo controlled double-blind study 
examined whether an oral creatine supplementation regimen would 1) increase muscle TCr 
content, 2) attenuate any loss in TAN or ATP during intermittent sprint training, and 3) 
have an ergogenic effect on performance after sprint training. Thirteen male endurance 
trained cyclists ingested 20 g of creatine monohydrate supplement or placebo per day for 7 
days, after which they ingested a maintenance dose of 2 g creatine or placebo per day for 
the remainder of the trial (15d). While on the maintenance dose, subjects performed 
intermittent sprint training (ST) on a cycle ergometer (10 x 10 s sprints with 140 s active 
recovery) for 6 consecutive days and a 7th day after one day of rest. Performance tests 
were performed before and after ST, and metabolic tests were performed on the 1st and 
7th day of ST. TCr increased significantly with creatine supplementation ( creatine group 
pre: 121 ± 4, post: 147 ± 9; vs. placebo group pre: 122 ± 4, post: 125 ± 4 mmol/kg dm; 
mean± SEM; p<0.05). The increase in TCr correlated with the percentage Type IIB 
fibres (r=0.95, p<0.005). By day 7 of ST, TCr content was no longer significantly higher 
than pre-supplementation levels despite the maintenance dose of creatine. ST resulted in a 
significant decrease in resting muscle TAN and ATP content in both groups (ATP content 
in creatine group pre: 24.1 ± 0.8, post: 17.2 ± 0.5; and placebo group pre: 26.5 ± 1.1, 
post: 18.0 ± 0.6 mmol/kg dm; p<0.001). During and in recovery from ST on day 7, both 
groups had lower plasma ammonia (p<0.05), hypoxanthine (p<0.001) and urate (p<0.001) 
accumulation than on day 1 of ST. There was no improvement in 1-hr cycle distance 
performance after ST, but peak sustained power output increased in the creatine group 
and not in the placebo group after ST (p<0.05). Peak and mean power during a 30 s 
Wingate test increased significantly (p<0.05) after ST but there was no additional 
ergogenic effect of creatine supplementation. In conclusion, this study shows that 1) the 
efficacy of muscle creatine uptake was dependent on the percentage of Type IIB fibres, 2) 
creatine supplementation and maintenance (2 g/d) did not attenutate ATP or TAN loss 
during 7 days of ST, 3) ST decreased the accumulation of plasma products of adenine 
nucleotide degradation and improved 30 s sprint performance, and 4) creatine 
supplementation and ST did not improve I-hr cycle distance performance. 
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Ergogenic aids may maximise the training and preparation for an athletic event, or 
improve performance during the event itself. The study of nutritional aids to performance 
has been of interest to both the scientist and the athlete for many years. Such studies often 
stem from other studies that examined factors which limit performance, and/or contribute 
to muscle fatigue . 
One of these observations is that the rapid depletion of intramuscular creatine phosphate 
(PCr) stores during high intensity exercise is associated with muscular fatigue (Sahlin and 
Ren, 1989). Despite no direct effect of PCr and creatine on actomyosin function, there 
appears to be a linear relationship between the onset of muscular fatigue and the 
decreasing levels of PCr. Hence the maintenance of high PCr stores and a high pre-
exercise level of PCr would be optimal in delaying the onset of fatigue and maximising 
total force production during an exercise bout/s (Hultman et al. , 1991 ; Hultman et al. , 
1967). 
Recently it has been shown that oral creatine supplementation can increase muscle creatine 
and PCr stores significantly (Harris et al. , 1992; Greenhaff et al., 1994a; Greenhaff et al. , 
1994A). This "creatine loading" phenomenon is analogous to the concept of increasing 
muscle glycogen content by carbohydrate ingestion. Research studies on this topic are 
relatively contemporary, and consequently in this thesis reference will be made to both 
published articles and to abstracts for which no full-length publication is yet available (the 
latter will be represented by an "A" following the year of publication). 
In addition to increasing muscle total creatine (TCr) content, oral creatine 
supplementation has been shown to enhance high-intensity short duration exercise 
performance (Balsom et al. , 1993; Birch et al. , 1994; Greenhaff et al. , 1993; Hall et al. , 
1995A; Jacobs et al. , 1995A; Lemon et al. , 1995A; Viruet al. , 1993). In contrast, other 
studies have not shown improved performance with creatine supplementation (Almada et 
al., 1995A; Burke et al. , 1995A; Cooke et al. , 1995; Grindstaff et al. , 1995A; Redondo et 
al. , 1995A). 
2 
This may be due to insufficient uptake of creatine into the muscle, since large variations in 
individual changes in creatine stores in response to supplementation have been shown 
(Greenhaff et al. , 1994a; Harris et al. , 1992; Lemon et al. , 1995A). The factors which 
influence the extent of creatine uptake need to be elucidated, but may include relatively 
low baseline (pre-supplementation) levels of total creatine (Greenhaff et al., 1994a; Harris 
et al. , 1992). 
The exact mechanism for an ergogenic effect is not yet clear, but from the alteration in 
metabolic effects of exercise that have been reported following creatine supplementation, 
it has been suggested that creatine loading has a beneficial effect on adenine nucleotide 
(AN) metabolism. Proposed mechanisms through which this occurs during exercise 
include increased PCr availability (Harris et al. , 1992) and more rapid PCr resynthesis 
(Greenhaff et al. , 1994a), better maintenance of adenosine 5'-triphosphate (ATP) 
concentrations, and perhaps a reduction in the extent of ATP loss during the later bouts of 
repeated high-intensity exercise (Greenhaff et al. , 1994A). 
Maximal high-intensity (sprint) exercise is characterised by an acute decrease in muscle 
total adenine nucleotide (TAN) and ATP content (Cheetham et al. , 1986; Gaitanos et al., 
1993; Sahlin and Broberg, 1990; Tullson et al., 1995), and similarly there is evidence that 
high-intensity training results in a depression of TAN or ATP stores which is not 
recovered immediately (Green et al., 1987; Hellsten-Westing et al. , 1993b; Stathis et al. , 
1994). Therefore, any factors which may prevent or attenuate the loss of AN from the 
muscle pool warrant examination. As discussed above, it is evident that an increase 
muscle TCr content affects the AN pathway during high-intensity exercise. It is 
hypothesised that creatine supplementation before and during high-intensity exercise 
training may attenuate the decrease in AN stores, and that this effect may manifest as an 
improvement in performance during and after training. 
In summary, the specific aims of this study are: 
i) to examine whether skeletal muscle fibre type composition influences the efficacy of 
creatine loading in human skeletal muscle; 
3 
2) to examine whether a loss in adenine nucleotide content as a result of consecutive days 
of intermittent sprint training is attenuated by prior creatine loading; and, 
3) to assess the effect of one week of concentrated intermittent sprint training on both 
sprint and high-intensity endurance performance, with and without prior creatine loading. 
CHAPTER 2: 
LITERATURE REVIEW 
2.1 Creatine: structure and origin 
Creatine (Cr) is a component of human skeletal muscle that can be derived from the diet 
or it can be endogenously synthesised. Approximately 95% of the body' s creatine pool is 
in the skeletal muscle, and the other 5% is predominantly in the heart, brain and testes 
(Balsom et al. , 1994). Consequently, endogenously synthesised creatine must be 
transported in the blood to the muscle. 
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At rest, creatine occurs in the muscle in two forms: free creatine (Cr, 35%) and 
phosphocreatine (PCr, 65%). The sum of these is the muscle TCr. Analysis of muscle 
biopsies from healthy individuals shows typical TCr contents between 120 and 130 
mmol/kg dry mass (dm)(which is approximately 120 gin a 70 kg male) (Harris et al. , 
1974; Harris et al. , 1992). The phosphocreatine content of Type II muscle fibres has been 
shown to be between 10% and 13 % higher than that in Type I fibres when measured in 
single muscle fibres (Greenhaff et al. , 1994b; Tesch et al. , 1989 respectively); or up to 
25% higher when comparing the levels in human vastus lateralis versus the predominantly 
Type I soleus muscle (Edstrom et al. , 1982). 
Creatine and PCr are broken down nonenzymatically to creatinine which is not 
reconvertible to creatine in significant amounts (Bessman and Carpenter, 1985). 
Creatinine excretion does not necessarily match creatine synthesis, but rather is excreted at 
a constant fraction of the creatine body pool, that is 1. 6% of the total creatine pool per 
day in humans (Crim et al. , 1976). Thus, in a 70 kg male with a TCr content of 
approximately 120 g, the turnover rate of creatine would be approximately 2 g per day. 
This is replaced by both endogenous and exogenous sources. 
Biosynthesis of creatine from the amino acids arginine, glycine and methionine occurs in 
the liver, pancreas and kidney. It appears that endogenous synthesis is regulated in part by 
dietary intake ( exogenous sources) via feedback mechanisms. Exogenous sources of 
creatine include foodstuffs such as raw meat and fish which have a high creatine content. 
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Creatine is found in some plant products in trace amounts only, hence daily intake of 
creatine is limited in a vegetarian or vegan diet (Delanghe et al. , 1989), and daily 
requirements of creatine rely on its endogenous synthesis (Balsom et al. , 1994). A study 
including two vegetarian subjects reported that their total muscle creatine contents were 
low, but within the normal range (Harris et al. , 1992). The noticeably lower serum 
creatine levels observed in vegetarians previously (Delanghe et al. , 1989), was 
accompanied by lower urinary creatinine excretion, and this was most probably a result of 
a mechanism to maintain muscle creatine content. 
The slow efflux of creatine from muscle tissue prevents large fluctations in muscle creatine 
content in both rest and exercise. Consequently, the body creatine pool has been viewed 
as remarkably stable. However, it has been shown that the administration of precursor 
amino acids arginine and glycine can increase the rate of creatine synthesis (Crim et al. , 
1976), and more recently that the size of the TCr pool can be manipulated by ingestion of 
large quantities of creatine (Harris et al. , 1992). 
2.2 Creatine: functions related to exercise 
It is well accepted that phosphocreatine, free creatine and inorganic phosphate (Pi) play 
pivotal roles in the regulation and homeostasis of skeletal muscle energy metabolism. In 
addition, the maintenance of PCr content is important for continued force production 
during high-intensity exercise (Greenhaff et al. , 1994a; Bessman and Carpenter, 1985). 
Indeed, the decline in force production during sustained static contractions and the 
restoration of force during the recovery period have been shown to be closely related to 
PCr levels (Sahlin and Ren, 1989). 
During exercise, the hydrolysis of ATP to adenosine-5'-diphosphate (ADP) and Pi releases 
energy required to fuel muscle contraction. Due to the relatively small amount of ATP 
that is stored in the muscle (4 mM) (Guyton, 1986), it must be continually resynthesised 
from secondary energy sources. These sources include immediate resynthesis from PCr; 
the pathways of glycolysis and glycogenolysis; and the more sustained process of 
oxidative phosphorylation in the muscle mitochondria. 
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Immediate resynthesis of hydrolysed ATP from its product ADP occurs by the provision 
of a high-energy phosphate, Pi, which is released from the breakdown of PCr to creatine. 
This allows the regeneration of ATP at, or near to, the active site of ATPases at the 
myofibril. The rate of this reaction is stimulated by relatively small declines in ATP 
concentration and the rise in concentrations of ADP and protons associated with muscular 
contraction (Sahlin and Broberg, 1990). During exercise of high-intensity and short 
duration, PCr levels may decrease to as low as 10-20% of the resting pre-exercise level 
( Greenhaff et al. , 1994a; Harris et al. , 197 6). Although PCr degradation occurs in both 
skeletal muscle fibre types during high-intensity exercise, the extent and rate of 
degradation has been shown to be markedly greater in Type II than Type I fibres during a 
3 0 s treadmill sprint ( Greenhaff et al. , 1994b) and 3 0 maximal knee extensions (Tesch et 
al. , 1989). 
The result of PCr degradation is a rise in the concentration of creatine close to the 
myofibrils. In order to maintain PCr levels, creatine is rephosphorylated at the 
mitochondria in the presence of oxygen. This process will be described in more detail 
later. The re synthesis of PCr is rapid and includes a fast and a slow component. After 
dynamic exercise approximately 84% of the deficit in PCr is restored within two mins of 
the cessation of exercise, and complete recovery is evident after 20 mins (Harris et al. , 
1976). The recovery in the total amount of PCr has been shown to be significantly lower 
after isometric compared to dynamic exercise (Harris et al. , 1976). This is probably due to 
comparatively reduced skeletal muscle blood flow (and hence aerobic potential) 
characteristic of the former type of exercise. Also, Tesch et al. (1989) reported that the 
initial rate of PCr resynthesis is greater in Type I compared to Type II muscle fibres, 
which again, is in accordance with the greater aerobic capacity of Type I fibres. 
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Since PCr can be used to near depletion easily, the amount of PCr stored in the muscle is 
an important factor when considering the extent to which it can contribute as a secondary 
energy source - especially during maximal high-intensity exercise. A reduction in the 
resting levels of PCr will result in a greater reliance on other secondary sources of ATP 
resynthesis such as glycolysis and glycogenolysis. During high-intensity exercise, oxygen-
independent glycolysis results in lactate and proton accumulation. The latter has been 
shown to be linked to poor acto-myosin cross-bridge function (albeit indirectly via a 
decrease in pH) and decreased muscular force production (Sahlin, 1992). Thus, during 
high-intensity exercise it is preferable to delay the reliance on oxygen-independent 
glycolytic ATP resynthesis. The rapid provision of energy by PCr and its efficient 
resynthesis makes it the major and preferred substrate for the resynthesis of ATP in muscle 
at the onset of exercise or during single or multiple bouts of exercise of high-intensity and 
short duration. 
Another biochemical function of creatine is that of an energy carrier between the 
mitochondria and the cytosolic utilisation sites. This is integrally related to the need to 
rephosphorylate creatine after PCr breakdown (as discussed previously), and the 
secondary resynthesis of ATP by mitochondrial oxidative phosphorylation. Creatine 
accumulation (from PCr breakdown) at the myofibril makes its diffusion gradient towards 
the mitochondria high. Thus creatine diffuses to the mitochondrial membrane where 
creatine kinase (bound outside the inner mitochondrial membrane) catalyses the 
resynthesis of PCr at the expense of mitochondrial ATP. The ADP formed stimulates 
ATP resynthesis by oxidative phosphorylation in the mitochondria. Although a small 
amount of ATP diffuses from the mitochondria to utilisation sites, it is predominantly 
creatine that transports the high-energy phosphate in the form of PCr back to the 
myofibril. Thus PCr functions as an energy carrier between the mitochondria and 
cytosolic utilisation sites. This mechanism is known as the "creatine-phosphocreatine 
shuttle", and it is based on the view that adenine nucleotides and creatine kinases are 
compartmentalised (Bessman and Carpenter, 1985). 
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There is, however, evidence that does not favour the importance of the shuttle mechanism 
in steady state intracellular diffusion of high-energy phosphate between mitochondria and 
myofibrils (Meyer, 1989). In a study using the creatine analogue ~-guanidinopropionic 
acid, Meyer ( 1989) showed that the normal creatine content of skeletal muscle is far in 
excess of what is required to support the shuttle effect. This result is consistent with a 
linear model of respiratory control by cytoplasmic nucleotides, in which the creatine-
kinase system acts as an adenylate buffer or chemical capacitor rather than an energy 
earner. 
During submaximal exercise, the major contributors to energy requirements are the 
oxidative glycolytic-glycogenolytic systems and oxidative phosphorylation - the latter 
contributing between 40% and 70% depending on the workload (for a review see Hawley 
and Hopkins, 1995). Although PCr is not required to provide Pi for ADP 
rephosphorylation immediately and rapidly during such exercise, it is through the shuttle 
mechanism that it plays a key regulating role. A possible benefit of increasing muscle 
creatine stores may be an improved capacity to transport energy via the shuttle, thus 
increasing the contribution of oxidative processes to the energy requirements and 
decreasing the utilisation of oxygen-independent glycolysis and glycogenolysis. In 
addition, related to the inhibition of glycolysis by high concentrations of PCr, both creatine 
and Pi aid the regulation of key glycolytic enzyme activities (such as phosphofiuctokinase 
(PFK), glyceraldehyde 3-phosphate dehydrogenase, and pyruvate kinase) and have a role 
in pH buffering (Walker, 1979). 
In addition to its role in energy transport and energy supply for muscle contraction, 
phosphocreatine also provides energy for protein synthesis. At least 70% of protein 
synthesis is dependent on the phosphagen energy source. Due to increased cycling of the 
creatine-phosphocreatine shuttle during exercise, the delivery of PCr to protein 
synthesising sites is increased, and thus may influence the muscle hypertrophy associated 
with exercise (Bessman and Carpenter, 1985). 
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2.3 Adenine nucleotide metabolism 
From the discussion above, it is clear that creatine is integrally related to adenine 
nucleotide (AN) metabolism. The regulation of AN metabolism is of particular 
importance during exercise when large, abrupt increases in the rate of energy transfer 
occur and thus the efficient control of nucleotide concentrations and their interconversions 
is essential. 
2.3.1 Metabolic pathways 
When AN degradation occurs, the concentrations of degradation products increase 
intramuscularly. Some of these may be used in the resynthesis of AN in the myocyte, 
while other compounds diffuse out of the muscle cell into the blood and can be described 
as being "lost" AN. 
During exercise, the energy demand of force production necessitates the hydrolysis of 
ATP by myosin ATPase. When the rate of ATP hydrolysis exceeds the rate of resynthesis, 
the concentrations of free ADP and adenosine 5'-monophosphate (AMP) increase. 
During maximal high-intensity exercise there is a decreased capacity to rephosphorylate 
ADP for the resynthesis of ATP. In order to maintain a high ATP:ADP ratio at the 
myofibril ( essential for the continuation of contraction), it is necessary that the myokinase 
reaction (ADP + ADP <=> ATP+ AMP) favours ATP production (for review see Tullson 
and Terjung, 1991). To facilitate this, and stabilise the relative ratios of ATP to ADP and 
AMP in this equilibrium, the further breakdown of the AMP that has accumulated from 
ATP hydrolysis is required. AMP can be broken down via two pathways. Firstly, it can 
be dephosphorylated to adenosine; and secondly, it can be deaminated by AMP deaminase 
to form inosine monophosphate (IMP), and ammonia (NH3) is released. The latter 
pathway is the main route of degradation in skeletal muscle (Sahlin et al. , 1978). 
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Ammonia produced by AMP deamination diffuses readily from the muscle into the blood 
(for review see Banister and Cameron, 1990) and during high-intensity exercise the 
concentration of this compound in the plasma provides a valid indication of intramuscular 
AN degradation. The extent of IMP and NH3 accumulation is dependent on the severity 
of the metabolic stress or energetic imbalance (which is determined by the intensity and 
duration of exercise) (Sahlin and Broberg, 1990). Acute decreases in intramuscular ATP 
concentration can be stochiometrically matched with IMP accumulation (Meyer et al. , 
1980; Sahlin et al. , 1978; Sahlin and Broberg, 1990). This can amount to 15% (Sahlin et 
al., 1978; Sahlin and Broberg, 1990), 20% (Tullson et al. , 1995), or even 32% (Gaitanos 
et al. , 1993) of the pre-exercise muscle ATP content when exercising maximally. 
When the energy demand persists, IMP is further degraded to inosine, hypoxanthine, 
xanthine and finally uric acid. In this catabolic pathway, adenine nucleotides can still be 
maintained in the muscle cell by three synthetic pathways: 1) from IMP via the purine 
nucleotide cycle (PNC); 2) from hypoxanthine via the purine salvage pathway; and 3) by 
de novo synthesis (for review see Tullson and Terjung, 1991). The former process 
involves the reamination of IMP to AMP, but does not occur to any significant degree 
during intense work conditions (Meyer and Terjung, 1980). The latter 2 processes are 
comparatively slow and expend comparatively larger amounts of energy, and thus are not 
favourable during exercise. Although some AN can be recovered, the appearance of 
hypoxanthine and uric acid in plasma is indicative of nucleotide loss from the muscle as a 
whole (Sewell and Harris, 1992). Thus plasma NH3, hypoxanthine and uric acid are 
commonly used as markers of intramuscular AN loss. Tullson et al. (1995) measured the 
appearance of such purines in the plasma during a 4 min high-intensity cycle, and 
calculated that they accounted for 82% of the decrease in total AN that was measured. 
During exercise (especially high-intensity exercise) it is optimal to maintain ATP levels to 
fuel ongoing contraction, and prevent AN degradation. It is possible that the hydrolysis 
products of AN degradation could have an indirect influence on muscle function (Sahlin, 
1992). Indeed, a review by Banister and Cameron (1990) described that high 
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concentrations of NH3 are thought to be neurotoxic, and exercise-induced 
hyperammonemia may be involved in the mechanism of muscle fatigue by its effect on the 
central nervous system ( e.g. motor incoordination). Therefore, comparatively less NH3 
release into the blood at a given exercise intensity could be beneficial to performance. 
2.3.2 The influence of exercise on adenine nucleotide degradation 
Maximal exercise has been shown to cause an acute decrease in total muscle nucleotides, 
due to the inability of the skeletal muscle to match ATP degradation with ATP resynthesis. 
As discussed previously, studies have reported decreases ofbetween 15% and 32% of 
resting ATP or AN levels immediately after exercise (Cheetham et al. , 1986; Gaitanos et 
al. , 1993; Sahlin and Broberg, 1990; Tullson et al. , 1995). Variation between studies in 
the reported "loss" of AN appears to be related to different intensities and duration of 
exercise, and also will be dependent on the many metabolic factors that regulate AN 
degradation. 
The extent of AN degradation and subsequent loss from muscle cells is dependent on the 
regulation of the pathway, and this occurs predominantly at the level of AMP deamination. 
At rest, AMP deaminase is most probably inhibited by the presence of Pi (Sahlin and 
Broberg, 1990). It is activated by increased free ADP and AMP concentrations, hydrogen 
ion (Ir) accumulation, and thus a lowering of intramuscular pH (Sahlin and Broberg, 
1990). Although the acidotic activation of AMP deaminase is an important mechanism in 
the enhanced rate of AN degradation during exercise (Sewell and Harris, 1992), the 
degree of acidosis is not a prerequisite for increased AMP deaminase activity and 
subsequent AN degradation (Dudley and Terjung, 1985b; Sahlin and Broberg, 1990). 
Sahlin and Broberg (1990) propose that AMP deaminase activity will be stimulated in any 
situation where ADP rephosphorylation to ATP is inhibited or limited. This includes 
conditions such as high-intensity exercise, glycogen depletion, and low aerobic capacity 
(such as the untrained state). In addition, the control of AMP deamination varies between 
the fibre types (see section 2.3 .3). There is also evidence to suggest that the initial (pre-
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exercise) muscle ATP concentration will influence the extent of its degradation. Green et 
al. (1987) examining the decrease in ATP concentration following multiple 60 s cycle 
sprint bouts showed that the greater the ATP concentration before the sprint bout, the 
greater the amount of ATP loss during that bout. 
2.3.3 The influence of fibre type composition on adenine nucleotide degradation 
The extent of AN degradation is influenced by muscle fibre type composition. Although 
IMP accumulates from AMP deamination in all fibre types, concentrations at fatigue are 
twice as high in fast-twitch fibres (Sahlin and Broberg, 1990). Using an animal model, 
Meyer and Terjung (1980) showed that AMP deamination was initiated at lower 
workrates in fast-twitch white fibres (glycolytic) as compared to fast-twitch red fibres 
(oxidative-glycolytic). Also, in a study on contracting skeletal muscle in rats, Dudley and 
Terjung (1985a) found that the activation of AMP deaminase in fast-twitch red fibres 
could be attributed to the increase in free AMP substrate alone; but the activation in fast-
twitch white fibres was due to factors other than the increase in substrate. Both of these 
separate findings imply that the control properties of this enzyme varies between fibre 
types. 
The activity of AMP deaminase is almost three-fold higher in fast-twitch white fibres 
(Tullson et al. , 1990). Dudley and Terjung (1985a) showed a decrease in AN ofup to 
50% in fast-twitch white fibres, while fast-twitch red fibres showed little depletion during 
contractions. The greater AN catabolism evident in fast-twitch white fibres appears to 
result from the inherent metabolic capability of the individual muscle fibres (including its 
activity and control), and the recruitment of fibres (Tullson et al. , 1990; Tullson and 
Terjung, 1991). 
Although the majority of studies examining fibre type and AN degradation have made use 
of the animal model, there are a few human studies as well. Greenhaff et al. ( 1994b) 
reported a decrease in ATP concentration of 3.5 mmol/kg dm in Type I, and 5.0 mmol/kg 
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dm in Type II fibres during a 30 s maximal treadmill sprint. This difference was however, 
not significant. 
Thus it is apparent that during a bout of high-intensity exercise where fast-twitch fibres are 
maximally recruited (Burke and Edgerton, 1975; Vollestad et al. , 1984), AN loss will be 
larger when compared to submaximal exercise. Also, it is possible that those athletes with 
a greater percentage of fast-twitch fibres will be more predisposed to AN degradation and 
loss. During high-intensity intermittent training - which is characterised by repeated 
periods of AN degradation and loss on consecutive days of training - this predisposition to 
lose AN is likely to be exacerbated. In addition, it has been shown that Type II (fast-
twitch) fibres have a slower de novo synthesis rate than Type I (slow-twitch) fibres 
(Tullson et al. , 1988). The question of whether de novo synthesis of AN restores TAN 
levels appropriately will discussed in Section 2.5.2. 
2. 3. 4 The influence of exercise training on adenine nucleotide degradation 
Hypothetically, the correlation between de novo synthesis rate and muscle oxidative 
capacity may imply that endurance training ( which increases mitochondrial content) may 
also increase the capacity for de novo synthesis and consequently attenuate the loss in AN 
from exercise. As indirect support for this theory, Tullson and Terjung (1991) report that 
endurance training decreases the extent of AMP deamination. 
Similarly, AMP deaminase activity is significantly reduced following high-intensity training 
(Hellsten-Westing et al. , 1993a). There is also evidence to suggest that both IMP and 
NH3 accumulation are reduced following high-intensity training (Tullson and Terjung, 
1991). These findings suggest that the activity of AMP deaminase has decreased 
following training. Indeed, in a study by Hellsten-Westing et al. (1993a) after a 2 min 
maximal cycle test, AMP deaminase activity was markedly reduced following 6 wks of 
sprint training. This study also described lower plasma accumulation of hypoxanthine and 
uric acid during the highest intensity of a 2 min maximal test after training. 
It is also highly likely that high-intensity training results in a more sustained decrease in 
AN stores which is not immediately recoverable (Green et al. , 1987; Hellsten-Westing et 
al. , 1993b; Stathis et al. , 1994). This will be discussed in more detail in Section 2.5.2. 
2.3.5 The influence of other metabolic pathways on adenine nucleotide degradation 
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During exercise, the rise in ADP and AMP concentrations are potent stimulators of the 
activation of both AMP deaminase and glycolytic enzymes, especially PFK. The 
relationship between the accumulation oflactate and NH3 in the muscle and plasma 
suggests that the increase in AMP deamination is directly activated by Ir associated with 
lactate formation (Sahlin and Broberg, 1990). In a study on trained thoroughbred horses, 
Sewell and Harris (1992) found that above a blood lactate concentration of 15 mmol/1, the 
relationship between plasma NH3 accumulation and blood lactate concentration was linear, 
and this relationship was similar to that between muscle IMP concentration and muscle 
lactate. The authors suggest that this described a threshold to AN degradation which was 
probably related to a sudden increase in AMP deaminase activity. 
It has also been shown that IMP formation is inversely related to muscle glycogen level 
(Sahlin and Broberg, 1990). A low initial muscle glycogen content prior to exercise to 
exhaustion at 70% V02 max resulted in a 5-fold greater increase in NH3 released from the 
muscle to the plasma (Broberg and Sahlin, 1989). Based on these findings, the authors 
suggest that during prolonged exercise to exhaustion, a shortage of carbohydrate substrate 
results in an increase in AMP deaminase activity. According to Lowenstein et al. (1972) 
the contribution of glutamate deamination to NH3 production is very low during high-
intensity exercise. However, this may not be the case during such exercise in a state of 
partial glycogen depletion, and thus ought to be considered. 
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2.3. 6 Conclusion 
Exercise, especially high-intensity exercise, results in the degradation and loss of adenine 
nucleotides. The extent of this loss is dependent on a variety of factors including: the 
exercise type, intensity and duration; fibre type composition; state of training; and the 
substrate available for energy production ( e.g. glycogen). The functions of creatine and 
phosphocreatine are intimately related to adenine nucleotide metabolism, and the 
importance of this link will become more clear as the effect of creatine supplementation on 
metabolism during exercise is discussed. 
2.4 Creatine supplementation and exercise 
The idea of creatine supplementation is not entirely new. Studies in the 1960' s and 1970' s 
examined the effect of altering creatine feeding to better understand creatine metabolism, 
pool size and turnover in man, and reference is even made to a study performed as early as 
1926 ( Chanutin, 1926). More recently, Crim et al. ( 197 6) fed various doses of creatine 
precursors ( arginine and glycine) to healthy men, and observed that the administration of 
dietary amino acid precursors can increase creatine synthetic rate. Gyrate atrophy of the 
choroid and retina is a disease characterised by impaired creatine biosynthesis. Sipila et al. 
( 1981) reported the successful treatment of such patients by administration of 1. 5 g 
creatine/day for a year. In summary, these data showed the following which is of 
relevance to this study: 1) the turnover rate of creatine is approximately 2 g per day in an 
average 70 kg male; 2) up to 95% of the body creatine pool is distributed in the skeletal 
muscle; and most interestingly, 3) the size of the body creatine pool can be influenced by 
the dietary creatine intake. 
The notion of creatine supplementation as an ergogenic aid to exercise performance, 
however, has only received scientific interest very recently. Also, the area of exercise 
metabolism concerning the effect of nutritional supplementation on short-duration high-
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intensity exercise capacity has tended to be overshadowed by the study of nutritional aids 
to endurance performance. This is surprising given that many sports events rely heavily on 
the "high-energy phosphate" energy pathways to resynthesise ATP and thus provide 
energy for muscular activity. This is the case in most team sports where exercise intensity 
varies and is characterised by bursts of maximal activity. In addition, athletes participating 
in endurance events also increase their exercise intensity intermittently, particularly during 
the final 30 seconds of a race. Although phosphocreatine is not a primary fuel source for 
the entire race, it may be of significant secondary importance during these periods of 
increased intensity. 
Since 1992, there has been a noticeable increase in the study of the combination of 
creatine supplementation and high-intensity exercise. 
2. 4.1 The effect of creatine supplementation on muscle total creatine stores 
A landmark study by Harris et al. (1992) showed that an oral supplementation regimen of 
5 g creatine monohydrate four to six times a day for more than two days resulted in a 
significant increase in total muscle creatine content. The 5 g dose was chosen as it elicited 
a plasma creatine concentration well in excess of 500 µmol/1 within an hour of ingestion, 
and repeated 5 g doses maintained this high level. Subsequently, most supplementation 
studies have followed a similar dosage protocol. Greenhaff (1995) suggests that low dose 
supplementation over a longer period ( e.g. 3 g/day for 1 month) is not as effective in 
raising muscle creatine levels as the 5 g/day protocol. In addition, it appears that 
following the 5 g/day regimen, a maintenance intake of 2 g/day will maintain stores at the 
high (loaded) level. The "wash-out period" or natural decline of creatine from the muscle 
following loading is currently being investigated. Odland et al. (1994A) used only 14 days 
as a washout period between 3 days of placebo or creatine ingestion in a cross-over trial 
apparently without basing this choice on scientific evidence. Lemon et al. (1995A) used a 
5 week washout period and reported that one subject's TCr content was still elevated at 
this time, suggesting that 5 weeks may not be sufficient time for TCr levels to return to 
baseline in all cases. 
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Harris et al. (1992) showed a mean increase in muscle creatine content from 127 mmol/kg 
dm to 149 mmol/kg dm in 17 subjects (20% increase). Similarly, Greenhaff et al. (1994A) 
showed a 19% (- 25 mmol/kg dm) increase in TCr stores following 5 days of creatine 
supplementation; and in another study Greenhaff et al. (1994a) reported that TCr content 
increased by approximately 15% after creatine supplementation. Also, preliminary results 
from 6 subjects who ingested 20 g of creatine per day for 6 days showed a mean increase 
in resting TCr of25 mmol/kg dm (Soderland et al. , 1994A). In Harris et al. ' s (1992) 
study only 20% of the observed increase was in the form of phosphocreatine. In contrast, 
Odland et al. (1994A) found that only free creatine concentration was significantly 
elevated after 3 days of creatine supplementation while PCr and TCr levels were not 
changed. Creatine uptake into the muscle appears to be greatest within the first 2 days of 
beginning supplementation, and by the 3rd day, 68% of the ingested dose was excreted in 
the urine (Harris et al. , 1992), suggesting that there is a limitation to the extent of creatine 
uptake. 
In Harris et al. ' s study (1992), there was noticeable variance between subjects in the 
extent to which they "loaded" with creatine. This is supported by Greenhaff et al. (1994a) 
who actually divided their analysis into a subgroup of"responders" (those subjects whose 
TCr content increased greater than 15%) and "nonresponders" (those subjects whose TCr 
content increased less than 10%) for further analysis. This observation was also noted by 
Lemon et al. (1995A) who, based on 
31P magnetic resonance spectroscopic (NMR) 
measurement of PCr, reported a prevalence of"nonresponders" to supplementation, 
although they do not clarify whether their classification of a "nonresponder" is based on 1) 
a lack of increase in PCr, 2) a lack of gain in mass, or 3) a lack of improvement in the 
performance test. Also, since 
31P NMR can only quantify PCr concentration, the lack of 
effect may be related to a lack of phosphorylation of the creatine taken up by the muscle. 
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Several factors are thought to affect this variance, although supporting data is still limited 
by relatively few studies and low subject numbers for some of the factors. Firstly, Harris 
et al. (1992) showed that in 5 subjects who performed one hour of hard one-legged 
exercise every day, the increase in TCr was significantly greater in the exercised leg than 
that observed in the sedentary leg. The extent of creatine uptake in athletes supplemented 
during training has not been investigated. Secondly, the greatest increases tend to occur 
in the subjects who had the lowest initial muscle creatine contents, especially those below 
120 mmol/kg dm ( Greenhaff et al. , 1994a; Harris et al. , 1992). In addition, there appears 
to be an upper limit to muscle creatine content in the region of 150 - 160 mmol/kg dm; 
which would imply that any loading effect of supplementation will depend in some cases 
on resting (pre-supplementation) creatine content (Greenhaff et al. , 1994a; Harris et al. , 
1992). The concept of tight control of muscle creatine content is shown in a study by Fry 
and Morales (1980) on skeletal muscle culture. They manipulated the extracellular 
creatine culture medium over a 5700-fold range, and this only altered the intracellular 
creatine content by a factor of 20. Thirdly, the fact that dietary ingestion of both creatine 
and arginine and glycine precursors influences endogenous creatine synthesis, implies that 
an athlete' s habitual diet may play a role in the extent to which he/she responds to creatine 
supplementation. 
Another factor to consider is that the dose of creatine in all studies has been administered 
independently of body mass. An equal dose for all athletes may not be ideal to maximise 
loading, since elite athletes may range in body mass between 40 kg (for a gymnast for 
example) to over 200 kg (for a weight lifter) . Also, although no studies to date have 
reported any harmful side-effects of supplementation, it may be of concern that the 
recommended loading dose is not set per kg body mass. In a study on 50 subjects 
between the ages of 19 and 85 yrs, Forsberg et al. (1991) reported that skeletal muscle 
TCr in relation to alkali-soluble protein was 1) significantly higher in females than males; 
and 2) not different between the ages . 
2.4.2 The effect of creatine supplementation on body mass 
Few studies have examined the effect of creatine supplementation on body mass closely. 
After creatine administration (20 g/day) for at least 5 days a mean increase in body mass 
of 1. 3 kg, 1. 8 kg, 1. 1 kg, 1. 0 kg, 1. 5 kg and 1. 6 kg was observed by Lemon et al. 
(1995A), Viruet al. (1993), Balsom et al. (1993), Stroud et al. (1994), Soderland et al. 
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( 1994 A) and Greenhaff et al. (1994a) respectively. The exact mechanism by which this 
occurs is not clear. Balsom et al. (1993) suggest that part of the increase in body mass 
may be due to an increase in total body water content. This is likely since creatine is 
highly charged, therefore to keep the sarcoplasmic osmolality constant when creatine is 
absorbed, the cells will tend to gain additional water. A part of the gain in mass may also 
be due to a form of structural change at the myofibrillar level, possibly by increased 
contractile protein synthesis (Balsom et al. , 1993). The theory of increase in protein 
synthesis is indirectly supported by Meyer et al. (1986) who report a decrease in fast 
twitch fibre diameter in creatine depleted rats, and similarly, Sipila et al. (1981) report an 
increase in fast twitch fibre diameter in patients fed creatine for the treatment of gyrate 
atrophy. In contrast, although earlier studies (Ingwall et al. , 1972; Ingwall et al. , 1974) 
indicated that creatine may increase the rate of myofibrillar protein synthesis in muscle 
tissue culture, more recently, the same group of researchers failed to confirm this 
phenomenon - despite the use of more up-to-date analysis techniques (Fry and Morales, 
1980). At this time, the effect of creatine administration on body mass still needs further 
clarification. 
2.4.3 The effect of creatine supplementation on exercise performance 
An ergogenic effect of creatine supplementation on exercise may be to either improve 
peak performance or to improve resistance to fatigue. Several studies have investigated 
the effects of creatine loading on various types of exercise ( Almada et al. , 199 5 A; Balsom 
et al. , 1993a; Birch et al. , 1994; Burke et al. , 1995A; Cooke et al. , 1995; Earnest et al. , 
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1995A; Greenhaff et al. , 1993; Grindstaff et al. , 1995A; Hall et al., 1995A; Jacobs et al., 
1995A; Lemon et al. , 1995A; Odland et al. , 1994A; Redondo et al. , 1995A; Viruet al., 
1993). However, few of these studies actually quantified whether or not there was a 
significant increase in muscle creatine content. It was assumed to occur, but whether this 
is actually always significant needs further evaluation. Thus, changes in performance, or a 
lack of change in performance should not be overinterpreted without evidence of the 
extent of creatine loading. 
In a study by Greenhaff et al. ( 1993 ), subjects performed 5 bouts of 3 0 maximal isokinetic 
knee extensions ( 1 min recovery) before and after creatine or placebo ingestion. After 
creatine ingestion, peak torque production was significantly increased throughout bouts 2, 
3, and 4; and at least part of bouts 1 and 5. Although muscle TCr was not directly 
measured by muscle biopsy sampling, or changes in body mass reported, the authors 
suggested that increasing muscle TCr increases both the amount of PCr available for 
contraction and also the creatine available for PCr resynthesis during exercise and/or 
recovery. They postulated that this increased rate of PCr resynthesis from mitochondrial 
ATP is due to increased efficiency of the PCr-Cr shuttle (thus suggesting that under 
normal conditions creatine availability may have a limiting role in the resynthesis of PCr). 
Another mechanism they mentioned that may contribute toward the enhanced performance 
with creatine ingestion, is increased buffering capacity. 
Lemon et al. (1995A), using a similar, though longer exercise protocol (20 bouts of 30 s 
isometric ankle extensions with 16 s recovery) also found an ergogenic effect of creatine 
supplementation on the maximum force generated and the total integrated force (in the 10 
min of exercise). During the creatine supplementation part of this cross-over design, 
subjects increased their mass (1.3 ± 0.3 kg) and increased their PCr/ATP ratio by 8%. 
One subject did not respond to creatine supplementation and thus was excluded from 
analysis. The authors do not clarify whether the subject was classified as a non-responder 
based on 1) a lack of increase in muscle PCr, 2) a lack of increase in body mass, or 3) a 
lack of improvement in performance. 
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Balsam et al. (1993a) examined the effect of 6 days of creatine supplementation on 
resistance to fatigue . After creatine ingestion, they found a significantly smaller decline in 
work output from baseline in 10 x 6 s bouts of high-intensity cycling at 140 revolutions 
per min (rpm) with 30 s passive rest after creatine ingestion, while the placebo group's 
performance was unchanged. Interestingly, no ergogenic effect was observed in resistance 
to fatigue (decline in work output) in the exercise test at 130 rpm, perhaps because the 
exercise intensity was lower (820 W vs. 882 Wat 140 rpm). Despite this lack of 
significant effect on performance, the exercise test at 130 rpm did result in a significant 
alteration in metabolism which will be discussed in more detail in sections 2.4.5, and 2.4.6. 
Another laboratory study (Birch et al. , 1994) investigated the effect of 5 days of creatine 
or placebo ingestion on 3 bouts of 30 s maximal isokinetic cycling (with 4 min passive 
recovery). They found that peak power output, mean power output and total work output 
in the first 2 of the 3 bouts was significantly increased in their supplemented group. In 
contrast to the studies showing an ergogenic effect in the latter bouts of intermittent 
exercise (Greenhaff et al. , 1993; Balsam et al. , 1993a; Viruet al. , 1993), in this study no 
effect of supplementation was observed in the 3rd exercise bout. The authors were also 
surprised at this finding, and suggested that the subjects' fatigue at that stage of the 
exercise was not related to energy substrate availability. This is possible as the decline in 
power during each cycle bout was approximately 11 %, while McCartney et al. ( 1986) 
reported a decline in power in the order of 20% during similar exercise in trained subjects. 
This suggests that the subjects in Birch et al. 's study (1994) may not have been 
particularly well trained and thus more susceptible to muscle contractile fatigue due to 
metabolite accumulation as opposed to fatigue due to substrate limitation. Also the 4 min 
recovery period was noticeably larger than that used in the other creatine studies. The 
potential significance of this will be discussed in Section 2.4.4. 
Following 6 days of creatine ingestion of 30 g/day, Viru et al. (1993) found a significant 
decrease in running time in the last bout of four 3 00 m ( -0. 7 s) and four 1000 m ( -5 . 5 s) 
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runs (with 4, and 3 min rest intervals respectively). This finding is interesting in that the 
previous studies had only shown an ergogenic effect in exercise of very short duration 
(bouts ofup to 30 s), while a 1000 m run lasting almost 2 mins is comparatively long and 
is considered a middle-distance event. During these exercise bouts, the heart-rate 
response was lower (statistical significance was not described) throughout the testing in 
the creatine loaded group despite the improved performance times. The authors 
suggested that there were enhanced oxidative processes in the skeletal muscle and . 
myocardium, especially during the recovery periods, but this interpretation remains to be 
tested by metabolic methods. 
It is apparent that an ergogenic effect is either evident in improved resistance to fatigue or 
improved peak performance, and not both. In Birch et al.'s study (1994), despite finding 
an increase in absolute power in each of the two first bouts following supplementation, the 
decline in power between bouts was very similar before and after supplementation and 
between the placebo and creatine group. Lemon et al.(1995A) also failed to show that 
creatine ingestion had an effect on the rate of force decline during the repeated exercise 
bouts, while maximum force values did improve. Thus, if there is a sufficient rest period, 
the rate of fatigue appears to be more a function of the exercise rather than the maximum 
power generated or the maximum TCr content. The improved resistance to fatigue and 
lack of improvement in peak power observed by Balsom et al. (1993a) was probably due 
to the limit imposed on peak power by having to cycle at prescribed revolutions per min. 
In another study (Earnest et al. , 1995A), peak anaerobic power (peak power in a 5 s 
period) also did not improve in 3 bouts of 30 s Wingate tests (5 min recovery); but an 
ergogenic effect of supplementation was evident in anaerobic capacity (total work in 30 s) 
which was greater in all 3 bouts of exercise after 14 days of creatine supplementation. 
Jacobs et al. (1995A) examined the effect of 5 days of creatine supplementation on 
maximal accumulated oxygen deficit (MAOD) - which is said to be a reflection of 
"anaerobic" exercise capacity. A significant ergogenic effect of creatine was evident in 
both the cycle time to exhaustion at 125% V02 max and the calculated MAOD, while the 
placebo group's performance and MAOD was unchanged. A noteworthy observation 
they made was that the enhanced MAOD was still elevated 7 days after the cessation of 
creatine treatment. 
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Another study (Hall et al. , 1995A) also investigated an indicator of anaerobic work 
capacity (YI' ). The linear relationship: W = W' + CP(t) (where W, total work; W', they-
intercept; CP, critical power; and t, time to exhaustion) was tested by subjects performing 
4 bouts of cycle ergometry at work-rates that would elicit fatigue between 1 and 10 mins, 
before and after creatine or placebo supplementation. Their results indicated that creatine 
ingestion increased W' ("anaerobic" capacity) but did not affect CP (which has been 
shown to relate to "aerobic" metabolic processes). 
In contrast to the studies discussed above, a few studies have failed to show any ergogenic 
effect of creatine supplementation. It should be borne in mind that none of the following 
studies actually quantified the change in muscle TCr content. It is possible that the lack of 
ergogenic effect may be a result of insignificant creatine loading. 
In a study by Cooke et al. (1995), subjects performed two 15 s cycle sprints separated by 
20 min of rest, before and after 5 days of either creatine or placebo ingestion. No 
differences were observed in peak power, total work or fatigue index between or within 
the groups. There are 2 noticeable differences between this study and the others discussed 
previously. Firstly, the rest interval of 20 min is at least 5 times longer than any study 
showing an ergogenic effect of supplementation. This is particularly relevant when 
considering that the ergogenic effect of creatine loading may be related to enhanced ATP 
and PCr resynthesis, and a long recovery period would negate this effect (See Section 
2.4.4). Secondly, the subjects in Cooke et al. ' s study (1995) were untrained and were 
requested not to begin a structured exercise program during the trial. This may be 
significant since Harris et al. (1992) noted that exercise during supplementation 
augmented creatine uptake by the muscle. Although the change in muscle TCr was not 
directly measured, the authors acknowledged that there is question as to whether creatine 
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loading actually increases muscle PCr significantly. They suggested that an ergogenic 
effect on a single bout of high-intensity exercise may be dependent on the increase in PCr 
alone and not free creatine as the latter would not benefit the cell with an enhanced 
phosphoryl transfer potential. Cooke et al. (1995) concluded that creatine 
supplementation does not aid this type of exercise in untrained men. 
Odland et al. (1994A) examined the effect of 3 days of creatine or placebo 
supplementation on a single bout of maximal cycling for 30 s (Wingate test). Despite an 
increase in skeletal muscle free creatine content, performance indices of power and fatigue 
were not changed. This lack of ergogenic effect may be related to the fact that only one 
bout of exercise was performed. As suggested by several studies showing an ergogenic 
effect of supplementation, the benefit only becomes apparent in the later stages of 
intermittent exercise. 
In a field investigation, subjects performed 3 x 60 m sprints before and after placebo or 
creatine supplementation for 5 days (25 g/day) (Redondo et al. , 1995A). There was no 
significant difference in running velocity between the groups before or after 
supplementation. In addition, in the event that an ergogenic effect only occurred in the 
latter stages of the run, the 60 m was divided into 3 parts for the analysis i.e. 20-30 m; 40-
50 m; and 50- 60 m, but this still did not show any performance improvement with 
creatine supplementation. Similarly, Burke et al. (1995A) failed to show any enhancement 
in 25 m, 50 m, and 100 m sprint swim performance, or in a 10 s maximal cycle ergometry 
test, following 5 days of creatine or placebo supplementation in a group of 32 elite 
swimmers. 
In a study by Grindstaff et al. (1995A) resistance trained males performed 5 x 15 maximal 
concentric repetitions on an isokinetic bench press and upright squat machine (60 s 
recovery) after 7 days of taking either maltodextrin or a mixed nutritional supplement 
containing 20 g of creatine per day. The only variable to improve significantly (6%) after 
supplementation with creatine was the absolute peak power generated in the bench press 
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test. No improvement was evident in peak power in the upright squat test. Also, average 
power, average force, peak force, total work, and all of these variables relative to body 
mass were unchanged in both tests. The authors conclude that creatine supplementation 
has limited effects on muscle endurance during intense, relatively slow-velocity resistance 
performance. In an extension of Grindstaff et al.'s study (1995A), Almada et al. (1995A) 
continued the same subjects' supplementation during 28 days of their normal resistance 
training. Although both groups showed an improvement in performance after the training, 
there was no difference between the placebo and creatine group for any of the variables 
measured. This is a novel finding as no other studies have examined the effect of 
supplementation during a period of high-intensity training. The results, however, should 
not be over-interpreted as, again, there was no muscle data to substantiate the extent of 
creatine loading that took place. 
Although the majority of the studies on creatine supplementation have been performed 
using short-duration high-intensity exercise, a few studies have examined its effect on 
endurance performance. In a study by Balsom et al. (1993b) subjects performed a 
treadmill run at 120 % V02max to exhaustion, and a 6 km terrain run before and after 
either creatine or placebo ingestion for 6 days. Contrary to expectation, after 
supplementation the creatine group showed a significant decrement in their terrain run 
performance, while the performance of the placebo group remained unchanged. The 
authors suggested that this finding may be related to the increase in body mass observed in 
the creatine group. Also, there was no change in the treadmill run in both groups. Stroud 
et al. ( 1994) examined the effect of 5 days of creatine supplementation on metabolic 
parameters during steady-state incremental treadmill run. There was no measurable effect 
of supplementation on respiratory gas exchange, blood lactate concentration, or heart-rate 
during and after the submaximal run. 
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2. 4. 4 The effect creatine supplementation on the resynthesis of PCr 
During maximal exercise, the depletion of muscle PCr stores is considered a significant 
factor in the limitation of force production and the onset of fatigue (Hultman et al., 1967). 
Consequently, the maintenance of these stores by continued and efficient PCr resynthesis 
is essential to sustain maximal exercise performance. The effect of creatine 
supplementation appears to be dependent on the extent of PCr hydrolysis during exercise 
and other factors which affect its resynthesis (discussed below). Two studies which 
reported improved performances only in the latter bouts of maximal exercise following 
creatine supplementation (Balsam et al., 1993a; Greenhaff et al., 1993) attributed their 
results to an increase in resynthesis of PCr during the recovery phase. 
Greenhaff et al. (1994a) examined the resynthesis of PCr following 20 electrically evoked 
1. 6 s isometric quadriceps contractions with 1. 6 s rest between each contraction before 
and after 5 days of creatine supplementation (20 g/day) . They found that although PCr 
resynthesis during the 1st min of recovery was similar before and after supplementation, 
during the 2nd min of recovery, the mean rate of PCr resynthesis was 42% higher 
following supplementation. It was apparent that those subjects who demonstrated the 
greatest increase in TCr following supplementation, also showed the greatest increase in 
PCr resynthesis rate after exercise. Greenhaff et al. (1994a) proposed that the 
improvements in work capacity with creatine supplementation reported in other studies 
may indeed be attributable to an accelerated rate of PCr resynthesis during recovery 
between exercise bouts. This is possibly the result of the increased availability of creatine 
driving the creatine-kinase reaction toward increased PCr production or an improvement 
in the creatine-PCr shuttle function. 
From their preliminary findings, Soderland et al. (1994A) reported that PCr concentrations 
immediately after five 6 s cylce sprints were higher after versus before creatine 
supplementation. 
27 
Therefore, it is possible that the ergogenic effect of creatine supplementation may be 
dependent on the recovery/rest interval between exercise bouts. An ergogenic effect of 
supplementation has been shown by Lemon et al. (1995A); Balsom et al. (1993a) and 
Greenhaff et al. ( 1993) who used 16 s, 3 0 s, and 60 s recovery intervals respectively. 
Such durations would coincide with the initial and steeper part of the exponential PCr 
resynthesis curve. However, after approximately 4 min, the advantage may be lost as the 
slope of the curve plateaus and sufficient time is provided for almost complete PCr 
resynthesis - and accordingly there would be less dependence on the rate of resynthesis as 
a limiting factor to performance. Birch et al. (1994) made use of a 4 min recovery period 
between 3 bouts of 3 0 s maximal isokinetic cycle sprints and failed to show any 
performance improvement in the latter bouts of the exercise. A lack of ergogesnic effect 
was also reported by Cooke et al. (1995), who used a 20 min recovery period between 2 
bouts of 15 s sprint cycling. 
2. 4. 5 The effect of creatine supplementation on lactate accumulation. 
The effects of creatine supplementation on lactate production and acid-base homeostasis 
were also investigated in some of these trials. Most of the studies report that plasma 
lactate accumulation, or post-exercise lactate concentration is not affected by creatine 
supplementation (Birch et al. , 1994; Greenhaff et al. , 1993; Greenhaff et al. , 1994a; 
Greenhaff et al. , 1994A; Odland et al. , 1994A). From their lactate findings, both Birch et 
al. (1994) and Greenhaff et al. (1993) suggest that glycogenolysis and/ or glycolysis is not 
directly affected by creatine ingestion despite increases in work output. Greenhaff et al. 
(1993) suggested that the energy for increases in work output observed was probably 
supplied by sources other that glycogenolysis ( considering that glycogenolysis and 
glycolysis would be maximally activated during this type of exercise). However, if the 
latter is not the case, then one could argue that the fact that lactate accumulation was 
similar despite an increase in work output may imply that creatine supplementation has 
resulted in a "down-regulation" of the glycogenolytic/glycolytic system at any specific 
workload. 
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In an analysis of all subjects, Greenhaff et al. (1994a) found that muscle lactate 
concentration after exercise was not significantly changed after creatine ingestion. 
However, in a sub-group (5 out of 8) of "responders" (those subjects who demonstrated 
a marked increase in muscle TCr following supplementation), Greenhaff et al.(1994a) 
reported a significant increase in muscle lactate concentration immediately after exercise 
of the same intensity after creatine loading. From this, they suggested that an explanation 
for the improvement in exercise performance could be that the contribution of anaerobic 
glycolysis to ATP production was enhanced after creatine supplementation. The authors 
did acknowledge that in this study muscle force production was not measured with 
sufficient precision for it to be accurately related to lactate accumulation. 
In contrast, preliminary findings have shown that muscle lactate accumulation immediately 
following five 6 s cycle sprints, and post-exercise muscle lactate concentration, were 
significantly lower after creatine supplementation despite more work being performed 
(Soderland et al., 1994A). Similarly, Balsom et al. (1993a) described lower post-exercise 
blood lactate accumulation after supplementation (11 vs. 9 mmol/1, and 7 vs. 5 mmol/1 pre 
vs. post-supplementation for each exercise intensity). This data led them to propose that 
there was a change in the source of energy production during the exercise. Despite more 
work being performed, non-oxidative glycolysis was apparently reduced. Their suggestion 
was that the "down-regulation" was due to the reduced accumulation of ADP and AMP 
rather than increased accumulation of inorganic phosphates (which would in fact "up-
regulate" glycolysis) . 
At this stage, data regarding the effect of creatine supplementation on lactate 
accumulation is inconsistent; especially considering that exercise duration is likely to be a 
critical factor. Thus conclusions or interpretations are not indisputable. 
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2. 4. 6 The effect of creatine supplementation on adenine nucleotide metabolism. 
The metabolic effect of creatine supplementation includes a decrease in plasma ammonia 
concentration during and after high-intensity exercise (Birch et al., 1994; Greenhaff et al., 
1993). Greenhaff et al. (1993) reported that the change in plasma ammonia concentration 
from baseline at the beginning of exercise was significantly reduced in the last 2 bouts ( of 
5 bouts) of exercise. Birch et al. ( 1994) showed that plasma ammonia accumulation at 2 
mins post-exercise was significantly lower after creatine supplementation (160 µmol/1 
vs.129 µmol/1) . This reduction in NH3 concentration occurred despite the subjects often 
performing more work. In contrast, Earnest et al. (1995A) reported that plasma ammonia 
accumulation 2 mins after 3 x 30 s bouts of cycling was unchanged following creatine 
supplementation. However, significantly more work was performed during these exercise 
bouts, thus the lack of change in NH3 concentration at a higher intensity of exercise may 
be indicative of a decreased accumulation at the same intensity with creatine ingestion. 
It has been suggested that the reduced plasma ammonia concentration represents an 
increase in the efficiency of rephosphorylation of ADP to ATP due to greater PCr 
availability (Greenhaff et al., 1993). In addition, this may imply that there was a decrease 
in the amount of muscle ATP degraded to IMP, and thus also a decreased potential to lose 
total nucleotide via further degradation to hypoxanthine and urate. 
Balsom et al. (1993a) measured plasma hypoxanthine concentrations after exercise, and 
observed that peak values decreased significantly from a mean of 21 to a mean of 17 
µmol/1 after an exercise test where on average more work was performed following 
supplementation (n = 8). They explained that their finding was an indication there had 
been a reduction in adenine nucleotide degradation. 
This theory was examined more closely in a study by Greenhaff et al. (1994A). The 
decrease of ATP during each of 2 bouts of 30 s maximal voluntary isokinetic exercise was 
measured immediately on cessation of exercise before and after creatine supplementation. 
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They reported that during the second bout of exercise, mean ATP reduction was 50% less 
following creatine ingestion despite subjects performing more work. From their 
preliminary findings, the authors suggested that the attenuation in ATP degradation with 
creatine supplementation is probably related to an improved maintenance of the rate of 
ATP resynthesis from ADP. 
2. 4. 7 Conclusion 
It is apparent that creatine supplementation may enhance athletic performance during 
some types of short, intermittent maximal or near-maximal exercise. Also, there is 
evidence to suggest that creatine supplementation has an effect on energy metabolism 
during exercise and recovery from exercise. There is noticeable variance in the extent to 
which performance and metabolic changes occur, and this may be related to the type, 
intensity, and recovery duration of the exercise tested. In addition, the extent of increase 
in muscle creatine content as a result of supplementation, and certain attributes of the 
athletes themselves (such as fibre type, or prior training) warrant consideration. 
2.5 High-intensity intermittent (sprint) exercise 
Few studies have examined the physiological responses to high-intensity intermittent 
(sprint) exercise, which is surprising as many sports such as soccer, hockey, and 
basketball, incorporate periods of high-intensity sprint bursts, and brief periods of active 
recovery. In addition, many endurance athletes make use of intermittent sprint training 
sessions to "peak" for competition or enhance their "power" energy systems. 
The majority of the energy required for such high-intensity short duration exercise is 
provided through oxygen-independent energy pathways. Exercise lasting less than 10 
seconds predominantly relies on the degradation of PCr, while energy during exercise of 
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up to 1 min is provided through both PCr breakdown, and glycolytic/glycogenolytic 
degradation of glucose and glycogen to lactate ( Gaitanos et al. , 1993). This was also 
shown in a study by Cheetham et al. ( 1986) which examined muscle metabolism during a 
maximal 30 s treadmill sprint. They calculated that the relative contribution to ATP 
production during the 30 s from glycolysis, PCr degradation, and ATP depletion, was 
63%, 32%, and 5% respectively. 
2. 5.1 High-intensity intermittent (sprint) training 
Research has shown that high-intensity training improves high-intensity exercise 
performance (Houston and Thomson, 1977; Linossier et al. , 1993; Nevill et al. , 1989; 
Nielson et al. , 1994). Nevill et al. (1989) reported a 12% improvement in peak power 
output during a 30 s treadmill sprint after 8 weeks of sprint training. Similarly, in a 30 s 
Wingate cycle sprint test after 7 weeks of training, increases in peak power ofup to 17% 
(Stathis et al. , 1994) and even 25% (Linossier et al. , 1993) have been reported. After 6 
weeks of training, anaerobic capacity as represented by the maximal accumulated oxygen 
deficit during a 30 s sprint run has also been shown to improve with sprint training in the 
order of 10% (Medbo and Burgers, 1990) and up to 17% and 20% as shown by 
performance time to exhaustion in a steep treadmill run (Houston and Thomson, 1977; 
Roberts et al. , 1982 respectively). Significant improvements in Sargent's jump 
performance and endurance at 50% of maximal voluntary contraction have been reported 
after 8 weeks of sprint training (Thorstensson et al. , 1975). Variance in the ergogenic 
effect of sprint training will obviously depend on the training status of the subjects, the 
exact nature and duration of the training, and the performance variables that are used to 
quantify any change. 
In contrast to conventional training studies that last more than 4 weeks, a significant 
increase in 5 s power output in a sprint cycle test has been shown in a group of subjects 
that performed intensive sprint training for only one week (Hellsten-Westing et al., 
1993b). 
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The mechanisms for such performance improvements have not been extensively examined. 
Adaptations to training have been observed in a variety of physiological systems including 
purine and glycolytic metabolism, enzymatic activities, and cardiovascular changes. For 
the purposes ofthis review, only those pertaining to purine metabolism and factors that 
affect it, will be discussed. 
2.5.2 The effect of high-intensity training on resting high energy phosphate stores 
Creatine and phosphocreatine levels in the skeletal muscle are remarkably constant and do 
not appear to change with high-intensity training (Green et al. , 1987; Hellsten-Westing et 
al. , 1993b; Houston and Thomson, 1977; Linossier et al. , 1993; Nevill et al. , 1989; Stathis 
et al. , 1994; Thorstensson et al. , 1975). However, one study (Boobis et al. , 1983A) 
reported that resting PCr concentration was significantly lower after 8 weeks of training. 
It should be noted that the relatively lower PCr content may just reflect that the muscle 
samples were taken with the subjects in a comparatively less "rested" state, or as discussed 
by Bangsbo et al. (1993), a low PCr may be due to its artefactual hydrolysis during 
freezing of the muscle sample. A more accurate reflection of the effect of training on PCr 
and Cr would be represented by total creatine content. 
Results from studies that examined the effect of high-intensity training on resting muscle 
adenine nucleotide levels are less consistent. A few studies have shown that post-training 
levels of muscle ATP are significantly decreased. In one of these studies (Stathis et al. , 
1994), subjects trained 3 times per week for 7 weeks during which they increased the 
number of 30 s cycle sprint bouts performed each session from 3 to 10 (with 4 min 
recovery between bouts, and 3 min recovery in the last 2 weeks). Training resulted in a 
19% and 18% reduction in resting muscle ATP and total adenine nucleotide (TAN) levels 
respectively. The authors suggested that this was likely to be the result of an imbalance 
between ATP degradation and resynthesis, and they attributed it to either the acute effect 
of the prior exercise bout; or to the chronic effect of the high-intensity training. The 
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observation that the ATP concentration did not return to pre-training levels after 48 to 72 
hours ofrest implied that the latter cause was more likely. Stathis et al. (1994) proposed 
that this may describe a training induced down-regulation in resting ATP concentration. 
Although such a training adaptation would seem to be a paradox, ATP concentration 
should not be seen as an energy store. It is not the size of the AN pool that is essential to 
its function but rather the relative ratio of ATP/ADP, both of which influence energy flow, 
that is important. At the onset of exercise a comparatively lower ATP concentration 
could result in earlier acceleration of ATP resynthesis or an amplification of the signal. 
Stathis et al. ( 1994) suggested that, due to the repeated depletion of ATP levels during 
intermittent exercise (as shown by McCartney et al. , 1986), there is probably a sustained 
elevation in IMP concentration during a sprint training session. Thus, repeated sprint 
training sessions provide a sustained environment of enhanced catabolism of IMP, which 
results in the diffusion of hypoxanthine and inosine from the muscle, and the subsequent 
and repeated loss of purine bases. 
In this study, despite a lower resting ATP content after training, subjects significantly 
improved their 30 s cycle sprint performance. This raises the question of whether sprint 
performances would have been further improved had subjects begun their post-training 
test with a higher resting ATP concentration. 
In a study by Green et al. (1987), subjects trained for 3 days performing a total of between 
14 and 24 bouts of 60 s sprints (with 240 s recovery) per day. By the 3rd day, resting 
muscle ATP levels had dropped by 20% (5 .03 to 4.03 mmol/kg wet weight) . The authors 
suggested that this may have been a result of either increased adenine nucleotide loss due 
to increased IMP formation, or perhaps a stress induced malfunction of the creatine-
phosphocreatine shuttle and consequent failure to replete ATP stores. If, however, the 
latter theory is correct, the failure to replete ATP stores would have resulted in an 
unusually high ADP concentration in the muscle - yet Green et al. (1987) reported that 
ADP levels were not significantly altered after exercise and training. 
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Hellsten-Westing et al. ( 1993b) also examined the effect of sprint (high-intensity 
intermittent) training on TAN levels. Both experimental groups underwent one week of 
intensive training on a cycle ergometer during which they performed fifteen 10 s maximal 
cycle sprints with 50 s rest between bouts twice per day. In addition, one group had 
trained 3 times per week for 6 weeks prior to the intensive week (performing one set of 
the aforementioned exercise per day). The group that trained for 6 weeks showed a 
decrease in TAN from a mean of 25 .1 to 22. 0 mmol/kg dm. The intense training week 
had no additional effect. The group that only trained intensely for one week showed a 
decrease in TAN levels from a mean of 25 .1 to 19 .4 mmol/kg dm. This decrease was still 
apparent 3 days after training had ceased. Analysis of plasma creatine kinase activity led 
the authors to conclude that high-intensity intermittent exercise training caused a decrease 
in resting levels of total muscle adenine nucleotides without a concomitant indication of 
muscle damage. 
This finding and the work of Stathis et al. ( 1994) both imply that an adaptation or 
response to high-intensity intermittent training may include a reduction in resting TAN 
concentration. In addition, those subjects that were non-specifically trained showed a 
significantly greater decrease in TAN than those subjects who underwent the initial 6 
weeks of training. This suggests that the extent of the reduction in TAN with training may 
be moderated by both the nature and duration of training, and prior exposure. 
As was found by Stathis et al. (1994), Hellsten-Westing et al. (1993b) also reported 
improvements in total work performed ( 6% to 8% increase) during a training session after 
the 6 weeks of training despite lowered skeletal muscle TAN content. 
In contrast to the work of Stathis et al. (1994), Green et al. (1987) and Hellsten-Westing 
et al. (1993b), a other sprint training studies have not shown a decrease in resting ATP 
levels 48 to 72 hours after the last training session. In a study by Nevill et al. (1989), 
subjects trained 4 times per week for 8 weeks (this included 2 days of 2 x 30 s treadmill 
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sprints with 1 O min recovery; 1 day of 6 to 10 x 6 s sprints with 54 s recovery; and 1 day 
of 2 to 5 x 2 min runs at 110% V02 max with 5 min recovery). They reported that resting 
ATP concentration was slightly, but not significantly, lower after training. Another study 
that examined intermittent treadmill sprint training 3 to 4 times per week for 8 weeks was 
performed by Thorstensson et al. (1975). Subjects completed multiple 5 s sprints (25 to 
55 s recovery), and over the 8 week period increased the number of repetitions (from 20 
to 40), the speed (from 19 km/hr to 24 km/hr), and the incline of the run. Despite small 
subject numbers (n = 4), the authors reported that there was no sigriificant change in 
resting ATP concentration after training. Similarly, no changes in resting ATP stores were 
found in subjects who performed intensive sprint training either 5 times per week for eight 
weeks (Boobis et al. , 1983A) or 4 times per week for 7 weeks (Linossier et al. , 1993). 
On the other hand, there are two studies that show an increase in ATP levels following 
intense training. Houston and Thomson (1977) reported a 15% increase in resting ATP 
concentration (from 25 to 29 mmol/kg dm) after 6 weeks of intense intermittent hill 
running 4 times per week. The training protocol was quite varied and included: 3 x 60 s 
sprints (2 min recovery), 5 x 6 s sprints (24 s recovery), and 2 x 90 s sprints (3 min 
recovery) . In this study, however, only 5 subjects were examined, and they were 
noticeably older (34 to 37 years) than those in the other studies. Eriksson et al. (1972) 
reported an increase in resting ATP concentration from 4.3 to 4.8 mmol/kg wwt. after 
training. Although the training employed was intermittent in nature, it was not strictly 
high-intensity as it included 15 to 20 min intermittent runs, some basketball and soccer 
games. 
In summary, it is apparent that the literature is inconsistent regarding the effect of high-
intensity training on resting muscle ATP stores. Both Stathis et al. (1994) and Hellsten-
Westing et al. (1993b) suggest that the discrepancies are best explained by differences in 
the training protocols used in each study. The difference does not appear to be related to 
the recovery interval between exercise bouts. Those studies that reported an increase in 
ATP stores following training used rest periods from 24 s to 3 mins; those in studies that 
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reported no change in ATP stores used rest periods from 25 s to 10 mins; and lastly, those 
studies that report a decrease in ATP stores used rest intervals between 50 sand 4 mins. 
The difference appears to be related more to the specificity of the exercise used. Those 
studies that showed a decrease in ATP concentration following training used training 
protocols that 1) were extremely strenuous, 2) made use of one type of exercise at 
maximal intensity, and 3) imposed a training overload by increasing repetitions of the 
exercise. In contrast, the other studies' training protocols incorporated a variety of 
exercise types and intensities. 
2. 5. 3 The effect of high-intensity training on products of adenine nucleotide 
degradation, enzymes activities, and the activity of oxygen-independent glycolysis. 
High-intensity intermittent exercise is characterised by large increases in plasma ammonia, 
hypoxanthine, and uric acid concentrations after exercise. There is evidence to suggest 
that high-intensity intermittent training results in an adaptation in purine nucleotide 
metabolism and hence alters the accumulation of such compounds. 
The large increase in plasma ammonia concentration after high-intensity exercise is 
significantly attenuated with sprint training (Snow et al. , 1992; Stathis et al., 1994). Snow 
et al. (1992) proposed that sprint training alters muscle NH3 eftlux and/or the removal of 
NH3 from the plasma rather than a decrease in muscle NH3 production. This argument, 
however, is based on the premise that ATP degradation during a bout of sprint exercise is 
unaltered by training (Nevill et al., 1989), but there is evidence to suggest the contrary. 
Stathis et al. (1994) report a 52% decrease in the extent of ATP degradation during a 
sprint bout after training. Thus there exists the possibility that the mechanism by which 
plasma NH3 accumulation is decreased after training is related to decreased ATP 
degradation and subsequent ammonia production. 
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Plasma accumulation of both hypoxanthine and uric acid following a 2 min maximal 
exercise test has been shown to be significantly lower after 6 weeks of sprint training 
(Hellsten-Westing et al., 1993a). The authors proposed three reasons for the decrease in 
hypoxanthine concentration following training. Firstly, it may be due to an increase in the 
amount of intracellular hypoxanthine that is rephosphorylated to IMP. This explanation is 
probable as Hellsten-Westing et al. (1993a) also report that the activity of the enzyme 
responsible for this conversion (hypoxanthine phosphoribosyl transferase, HPRT) was 
higher after training. This would be a beneficial adaptation to training as it would reduce 
nucleotide loss from the muscle. The second explanation for the decrease in hypoxanthine 
accumulation is that less hypoxanthine was actually produced during the exercise. This 
explanation also seems feasible as the authors found that the activity of AMP deaminase 
was markedly decreased following training. This down-regulation would result in lower 
IMP and ammonia accumulation, thus explaining the decrease in degradation of IMP to 
purines. The third explanation is that after training, there was less dependence on adenine 
nucleotide degradation for the resynthesis of ATP at the same workload. This would be a 
result of an enhanced ability to resynthesise ATP via oxygen-independent glycolysis - and 
this theory is supported by their finding that PFK activity was increased after sprint 
training (Hellsten-Westing et al., 1993a). 
Linossier et al. ( 1993) also proposed that sprint training results in an increase in the 
contribution to energy production from oxygen-independent glycolysis during high-
intensity exercise. They reported a 20% increase in both PFK and lactate dehydrogenase 
(LDH) activities and a corresponding increase in post-exercise lactate accumulation after 7 
weeks of sprint training. Even greater increases in PFK and LDH activities were 
described by Roberts et al. (1982) after a 5 week training period which included 3 to 4 
sessions per week of multiple 200 m sprints. Stathis et al. (1994) suggested that the most 
likely source of an improved ATP resynthesis rate with sprint training is an enhanced 
glycolytic capacity. Also, based on estimations from changes in muscle metabolites, Nevill 
et al. (1989) reported that in a 30 s sprint after training, total ATP resynthesis from 
anaerobic sources increased by 14%, and 20% of this increase was from anaerobic 
glycolysis. 
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There are, however, studies which do not support the theory that sprint training increases 
oxygen-independent glycolytic activity. Both Thorstensson et al. (1975) and Housten and 
Thomson (1977) failed to show an increase in LDH activity which was used as a marker 
of oxygen-independent glycolysis. Thorstensson et al. (1975) did, however, report an 
increase in the activities of myokinase (MK), adenylate kinase (AK) and creatine-
phosphokinase (CPK) following the 8 weeks of sprint training - implying that the capacity 
for ATP turnover was higher following training. In contrast, Hellsten-Westing et al. 
(1993a) report that AK activity did not change after training. Inconsistencies apparent in 
the literature are probably due to differences in training regimens used in each study, and 
the extent to which the training str~ssed the phosphagen system alone, or the phosphagen 
and oxygen-independent glycolytic systems together. 
When examining studies on the adaptations to sprint training, it should be borne in mind 
that adaptive responses are subject to the principle of specificity and individuality. This is 
shown in a study by Saubert et al. (1973) who used an animal model to examine the effect 
of 11 weeks of high-intensity intermittent sprint training on certain key glycolytic enzyme 
activities. Saubert et al. (1973) found that the soleus was the only muscle that showed an 
enzymatic adaptation to the sprint training (shown by increased phosphorylase and 
pyruvate kinase activities) . The authors concluded that prior to training, the glycolytic 
capacity of this muscle was so low, and thus an adaptation was necessary to meet the 
functional and metabolic demands of the daily sprint exercise. Those muscles with an 
adequate glycolytic capacity prior to training did not improve this capacity further with 
training. 
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2. 5. 4 Conclusion 
If high ATP degradation rates during sprint training result in an inability to completely 
restore the purine base loss during rest days, intramuscular ATP and TAN levels at rest 
will be reduced. It is unknown how long it takes for de nova synthesis to replete 
"chronically" depressed TAN levels since no studies have made measurements more than 
3 days post-training. 
High-intensity intermittent training results in adaptations that can attenuate a loss in 
adenine nucleotides which if prolonged and progressive could potentially affect 
performance or the ability to train efficiently. This is achieved through alteration in both 
absolute levels of purine compounds (resting ATP; and urate; hypoxanthine; and ammonia 
during exercise), and purine turnover as shown by enzyme activities (AMP deaminase; 
myokinase; creatine phosphokinase, HPRT). It is apparent that the rate of decrease in 
adenine nucleotide content of skeletal muscle resulting from the initial demands of high-
intensity training may be slowed down by continued training. 
This is an important practical consideration for the athlete in training. Most endurance 
athletes will "peak" for an event by increasing their exercise intensity and developing the 
"power" energy systems. It is at this point that strategies to optimise and prepare for this 
increase in training intensity need to be employed. It is not known whether the 
improvement in exercise performance following high-intensity training may be even 
greater if the muscle ATP pool could be maintained. 
2.6 Summary and hypotheses: the effect of prior creatine 
supplementation on adenine nucleotide metabolism during 
sprint training 
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One of the issues raised in previous studies on creatine supplementation was that some 
subjects did not respond to supplementation and thus did not enhance their total creatine 
content significantly. The prevalence of"non-responders" and, possible reasons for this 
need to be examined before results from these studies can be applied to the greater 
sporting population with confidence. 
It has been established that creatine supplementation enhances performance in high-
intensity intermittent exercise (Balsom et al., 1993; Birch et al., 1994; Earnest et al., 
1994A; Greenhaffet al., 1993; Hall et al., 1995A; Jacobs et al., 1995A; Lemon et al., 
199 5 A; Viru et al., 1993). This ergogenic effect is most probably a result of enhanced 
control of adenine nucleotide metabolism. In addition, high-intensity intermittent training 
causes a decrease in adenine nucleotide stores (Green et al. , 1987; Hellsten-Westing et al., 
1993b; Stathis et al. , 1994). An interesting question that arises from these separate short-
term studies, is whether creatine administration during the acute phase of high intensity 
training can prevent the observed loss in muscle adenine nucleotide stores. The possible 
mechanism explaining any or all of the above hypotheses is that higher muscle TCr stores 
result in a better maintenance of the adenine nucleotide pool and its metabolism. If this is 
the case, performance improvements from high-intensity sprint training may be enhanced 
with creatine supplementation. To date, no study has investigated whether an increased 
availability of phosphocreatine does in fact improve the adaptation to high-intensity 
training. 
This study will examine some of the questions raised above, namely: 
i) whether skeletal muscle fibre type composition influences the efficacy of creatine 
loading in human skeletal muscle; 
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ii) whether the decrease in skeletal muscle adenine nucleotide content from sprint training 
is attenuated by creatine loading and maintenance; and, 
iii) whether the effect of sprint training on both sprint and high-intensity endurance 




3.1 Exercise performance tests 
3.1.1 Peak sustained power output test 
The peak sustained power output test (PSPO) according to the protocol of Hawley and 
Noakes (1992) involved an incremental cycle to volitional fatigue on a Lode cycle 
ergometer (Lode, Gronigen, Netherlands). The initial workload was 3.33 watts/kg body 
mass, followed by two 50 watt (W) increments, after which the increment in workload 
was 25 W until exhaustion. Each workload was maintained for 2 min 30 s. PSPO was 
calculated by the equation: PSPO = Wrmat + (L\WL x t / 150), where Wrmat is the last 
completed workload, and tis the time (s) that the final uncompleted workload was 
sustained, and L\ WL is the workload increment. Subjects were required to remain seated 
throughout the test. The test was terminated on indication of exhaustion from the subject, 
or when the pedal cadence dropped below 60 revolutions per min (rpm). 
3.1. 2 Wingate anaerobic power test 
The Wingate anaerobic power test (WAT) was performed on a mechanically braked 
Monark cycle ergometer (Monark, Stockholm, Sweden), interfaced with an Apple 
microcomputer (Apple, Chicago, Illinois, USA). The ergometer was modified with racing 
handle-bars and cleat pedals. Subjects performed a standardised warm-up of 10 min of 
light cycling interspersed with some sprint bursts. The workload chosen for the well-
trained subjects was 0.1 kilopond/kg body mass. The power output measurements were 
not corrected for inertia of the fly-wheel , but power measurements were not initiated until 
the cyclist attained unresisted acceleration of the fly-wheel. From this test, measurements 
of peak power, mean power, peak cadence, and fatigue rate were made. Peak cadence 
was measured by a photo-optic sensor on the side of the ergo meter' s wheel, and the other 
variables were calculated by the on-line computer program according to the following 
equations: peak power (W) = workload (kiloponds) x peak cadence; mean power (W) = 
(I: power at each second) I 30; fatigue rate (W/s) = (peak power - power at t = 30 s) / 30. 
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3.1.3 1-hr Distance trial 
During the 1-hr distance trial subjects were required to cycle as much distance as possible 
in an hour using self-selected workloads. The test was performed on a Kingcycle 
ergometer (Version 4.1, 1991 , EDS Portaprompt Ltd, High Wycombe, Bucks). The 
advantage of this system is that it allows cyclists 1) to be tested in the laboratory, but 
under conditions that approximate road cycling more closely; and 2) to use their own 
bicycle. The reliability of this system was shown in a study by Keen et al. (1991A) who 
showed that the test retest correlation of maximal aerobic power tests performed on the 
Kingcycle was 0.98. 
The bicycle was supported by resting the bottom bracket on an adjustable prop and 
attaching the front forks to the frame of the ergometer. The prop was adjusted to 
standardise the amount of rolling resistance applied to the rear wheel of the bicycle. 
Power was produced by the rolling of the rear tyre against a calibrated air brake and 
flywheel. The mass of the flywheel and the resistance of the air brake were engineered so 
as to simulate the inertial load experienced by a 70 kg cyclist and his/her bicycle. Power 
output and cycle revolutions per min were measured by a system of photo-optic cells. The 
ergometer system was linked to an IBM compatible PC which displayed and recorded data 
continuously. 
Prior to each 1-hr test, the Kingcycle was calibrated to ensure that the results of tests were 
both valid and repeatable. Using a run down technique, the King cycle computer software 
calculated the extent to which the rolling resistance must be altered for the mass of the 
cyclist and his/her bicycle on the ergometer, and the adjustable prop was altered manually 
accordingly. 
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3.2 Blood sampling and analysis 
For blood sampling, a Jelco teflon cannula was inserted into a forearm vein and attached 
to a 3-way stopcock. To maintain its patency, the cannula-stopcock unit was routinely 
flushed with heparinised saline (1 ml heparin in 100 ml saline) (Sabax Sodium Chloride 
0.9% Sabax Ltd, Johannesburg, South Africa)(l ml Heparin = 5000 units, Pularin, Allen, 
Wadeville, South Africa) after each blood sample was taken. 
At each sampling time, a 2 ml blood sample was drawn and discarded in order to remove 
any saline that may have been present in the cannula-stopcock unit. Then a 4 ml blood 
sample was withdrawn and injected into a stoppered test tube containing EDT A. This was 
mixed and centrifuged (Sigma, Laborzentrifugen, GmbH, Germany) immediately for 6 min 
at 3000 rpm (- 2200 g) at approximately 4° C. Directly after the trial some plasma from 
each sample was enzymatically assayed for plasma ammonia concentration using the 
prepackaged kit method (Boehringer Mannheim GmbH, Mannheim, Germany) and the 
remaining supernatant was stored at -20° C for later analysis of plasma lactate, urate and 
hypoxanthine concentrations. Lactate was analysed using a prepackaged kit method 
(Lactate Kit PAP, BioMerieux, Lyon, France), while hypoxanthine and urate were 
analysed by high performance liquid chromatography (HPLC). 
3.2.1 HPLC analysis method for plasma urate and hypoxanthine 
a.) Sample Extraction 
A 100 µl volume of plasma sample was deproteinised in 100 µl of cold O. 6 M HPLC-
grade perchloric acid (PCA) (BDH, Hipersolv, England) and then mixed on a rotary 
mixer. The solution was then centrifuged in an micro-centrifuge (Eppendorf, Geratebau, 
Germany) at 11500 rpm (- 8500 g) for 4 min. A 150 µl aliquot of the supernatant was 
then neutralised with 9 µl of2.5 M potassium carbonate (K2C03, Univ AR, Saarchem Pty 
Ltd, Krugersdorp, SA). After this was thoroughly mixed, it was placed on crushed ice for 
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approximately 10 min to precipitate the potassium perchlorate salt. Following this, the 
solution was centrifuged as above for a further 4 min. Then, a 100 µl aliquot was mixed 
with 400 µl of the mobile phase phosphate buffer (see below). A small volume (20 µl) of 
this extracted sample solution was used for injection onto the HPLC column. 
b.) Mobile Phase Buffer 
The mobile phase consisted of a 50 mM potassium dihydrogen orthophosphate (KH2P04) 
(BDH, Hipersolv, England) buffer which was made up with deionised water(> 14 Mn). 
The pH of the buffer was 4.65 . The buffer was filtered through a 0.45 µm nylon 
membrane filter (Supelco Inc., Bellafonte, PA) and degassed before use. 
c.) Standard Solutions 
Stock solutions of both hypoxanthine (1.521 mmol/1) and urate (3 mmol/1) were made up 
in advance of the analysis and were stored at - 20° C as frozen 1 ml aliquots. On each 
analysis day, new stock aliquots of each compound were thawed and used to make up 
fresh standard solutions. Two standard solutions were used and were made up to a 
volume of 1 ml with the mobile phase buffer: standard 1 (hypoxanthine = 50.19 µmol/1, 
urate = 456 µmol/1) and standard 2 (hypoxanthine = 19.77 µmol/1 , urate = 306 µmol/1) . 
The compound concentrations in the two standards were chosen to cover the range of 
hypoxanthine and urate concentrations typical of human plasma at rest and after high-
intensity exercise. 
In order to calculate the concentration of the sample, it was necessary to quantify the area 
under the peak of each standard. On each day, the final standard area of each compound 
was taken as the average of the two standard areas for that compound. The 
reproducibility of the standard areas between each run and each day was good and this is 
displayed in Table 1. 
TABLE 1. Coefficient of variation (CV) in the peak area ofhypoxanthine and urate 
within the standard runs on each day, and between the standard runs over 
all analysis days. 
Mean within day CV 







Since the coefficient of variation was better within each day than between days, each 
plasma sample concentration was calculated using the mean standard area of the day on 
which it was analysed. 
d.) Analysis 
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After completion of all the exercie tests, samples were analysed in a random order on 11 
consecutive days. The samples were analysed using a Gilson HPLC system ( Gilson 
Medical Electronics, France) with Gilson software. The column was an Alphasil SODS 
(25 cm x 4.6 mm, HPLC Technology, Cheshire, UK). The Gilson 119 ultraviolet (UV) 
detector (Gilson Inc., Middleton, USA) was set at 249 nm. The chromatography was 
performed at ambient temperature and the flow-rate was 1 mVmin for the duration of the 
10 min run-time. From the extracted sample solution, 20 µl was injected through a 20 µl 
loop in the injection port (Rheodyne 7161 , California, USA). Data collection only 
commenced after 4 min because during the inital 4 min of the run a variety of intefering 
peaks eluted which were of no consequence to the run. From the beginning of data 
collection, the elution time of hypoxanthine was 4.27 ± 0.42 min, and that for urate was 
2.45 ± 0.38 min. The analysis conditions included a peak width of0.5 min, and peak 
sensitivity of 5%, and compounds were quantified according to peak area. 
Chromatograms of a standard and a muscle sample are presented in Appendix IV. 
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3.3 Muscle sampling and analysis 
Muscle was sampled from vastus lateralis on 3 occasions using the percutaneous needle 
biopsy technique described by Bergstrom (1962), as modified by Evans et al. (1982). All 
biopsies were taken with the subject at rest, and at the same time of day. 
Muscle biopsies were performed by a qualified and experienced medical doctor under 
sterile conditions. The biopsy site was cleaned, and 3 ml of 1 % lignocaine (Intramed Pty 
Ltd, Port Elizabeth) was injected subcutaneously. Once the local anaesthetic had taken 
effect, a scalpel incision (±1 cm) to the level of the muscle was made. Following this, the 
biopsy needle was inserted into the muscle, and a sample was taken. The site was cleaned 
and dressed appropriately. 
On removing the muscle sample from the biopsy needle, it was frozen in liquid nitrogen 
immediately. The estimated time lapse from removal to freezing was less than 5 s for the 
2nd and 3rd biopsies, and less than 10 s for the 1st biopsy as a section of this sample was 
cut off to be used for fibre type analysis. 
The muscle samples were initially stored at -80° C, and then freeze-dried for subsequent 
analysis of Cr, PCr, ATP, ADP, and AMP using HPLC. This analysis was based on the 
isocratic method for the simultaneous determination of creatine compounds and adenine 
nucleotides descibed by Sellevold et al. (1986) with modifications that will be described 
later (see section 3.3 .2). 
3. 3.1 Fibre type analysis 
Fibre type analysis was performed by the Pathology Department of Red Cross Hospital 
using the method described by Dubowitz (1985). The piece of muscle cut off was kept on 
ice for approximately 15 min, and then under a microscope was mounted on a slice of cork 
and prepared for fixing with a small amount ofTissue-Tek. The samples were frozen by 
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immersion and agitation in N-pentane pre-cooled to just above freezing point by liquid 
nitrogen. Samples were stored in air tight containers at - 80° C. Transverse sections (5 -
7 microns) were stained for ATPase activity at pH 9.4 for analysis of the 2-fibre 
classification system, and after preincubation at pH 4. 3 and pH 4. 6 for distinction of Type 
IIA and Type IIB fibres according to Brooke and Kaiser (1970). The fibre type 
proportions of approximately 150 Type I, Type IIA, and Type IIB muscle fibres 
differentiated by ATPase staining were measured using an IBAS Kontron Image analysis 
system. 
3.3.2 HPLC analysis method for skeletal muscle creatine compounds and adenine 
nucleotides 
a.) Sample Extraction 
The freeze-dried muscle sample was dissected free of visible blood and connective tissue 
and then powdered. Approximately 5 mg of sample was extracted via graded 
homogenisation. This involved adding an initial 100 µl of cold O. 6 M HP LC-grade PCA 
(BDH, Hipersolv, England) to the sample powder in a glass vial, and homogenising for 
approximately 2 min or until a milky paste was obtained. An additional 900 µl of PCA 
was then added to wash off any traces of the homogenate solution on the glass plunger. 
The homogenate was poured into an eppendorf tube, mixed on a rotary mixer and then 
centrifuged (Eppendorf, Geratebau, Germany) at 11500 rpm (-8500 g) for 4 min. A 200 
µl aliqout of the supernatant was then neutralised with 21 µl of2.5 M K2C03 (Univ AR, 
Saarchem Pty Ltd., Krugersdorp, SA). This was well mixed and placed on crushed ice for 
approximately 10 min to precipitate the potassium perchlorate salt. Following this, the 
solution was centrifuged as above for a further 4 min. From this, a 100 µl aliquot was 
mixed with 900 µl of the mobile phase phosphate buffer. A small volume (20 µl) of this 
extracted sample solution was used for injection onto the HPLC column. 
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b.) Mobile Phase Buffer 
This analysis method is based on the isocratic method described by Sellevold et al. (1986). 
They prescribed using a phosphate (KH2P04) concentration of 215 mM. From their 
study, it was shown that such a high salt concentration resulted in significantly decreased 
retention times of all compounds. In this study however, a buffer containing 215 mM 
phosphate did not give a distinct separation of compounds or a satisfactory baseline. 
Hence, through trial and error, a phosphate concentration of 90 mM was chosen. The 
increased retention time associated with lower salt concentrations in the mobile phase was 
overcome by altering the flow-rate in the later stages of the run. 
The final mobile phase contained 90 mM KH2P04 (BDH, Hipersolv, England); 2.3 mM 
tetrabutylammonium hydrogen sulphate (TBAHS) (TCI-Ace, Tokyo Kasei Kogyo Co 
Ltd, Tokyo); and 3.5% HPLC-grade acetonitrile (BDH, Hipersolv, England). After the 
addition of the acetonitrile, the pH was adjusted to 6.25 with 40% potassium hydroxide 
(KOH, BDH, Analar, Poole, England), and then the solution was made up to volume with 
deionised water(> 14 Mn). The mobile phase was filtered through a 0.45 µm nylon 
membrane filter (Supelco Inc., Bellafonte, PA) and degassed before use. 
c.) Standard Solutions 
Stock solutions of all the compounds (ATP, ADP, AMP, PCr, Cr, Creatinine (Cn), urate, 
hypoxanthine (Hx) and nicotinarnide adenosine dinucleotide (NAD)) were made up in 
advance of the analysis and were stored at - 20° C as individual 1 ml aliquots. On each 
analysis day, new stock aliquots of each compound were thawed and used to make up 
fresh standard solutions. Two standard solutions were used and were made up to a 
volume of 1 ml with the mobile phase buffer. The compound concentrations in the 
standards were chosen to cover the range of compound concentrations typical of human 
muscle at rest and after high-intensity exercise. 
In order to calculate the concentration of the sample, it was necessary to quantify the area 
under the peak of the standard. Each day, this was taken as the average of the two 
standard areas. The reproducibility of the standard areas between each run and each day 
was good and this is displayed in Table 2. 
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TABLE 2. Coefficient of variation (CV) in the peak height of PCr and Cr, and the peak 
area of ATP and ADP within the standard runs on each day, and between the 
standard runs over all analysis days. 
Mean within day CV 













After completion of all the exercise tests, the muscle samples were analysed in a random 
order on 4 consecutive days. The samples were analysed using a Gilson HPLC system 
(Gilson Medical Electronics, France) with Gilson software. The column was an Alphasil 
SODS (25 cm x 4.6 mm) (HPLC Technology, Cheshire, UK). The Gilson 119 UV 
detector (Gilson Inc., Middleton, USA) was set to dual wavelength detection mode; that is 
210 nm for the creatine compounds and 260 nm for the adenine nucelotides. The 
chromatography was performed at ambient temperature. The duration of the run was 20 
mins. For the first 8 min the flow-rate was 0.6 ml/min, then over 1 min it was increased to 
1.2 ml/min. This was maintained until the 19th min, afterwhich the flow-rate was reduced 
to baseline (0.6 ml/min) by the 20th min. 
From the extracted sample solution, 20 µl was injected into the injection port (Rheodyne, 
7161 , California, USA). The elution times (min) of the compounds were as follows : 
Cr = 4.64 ± 0.4; Cn = 5.23 ± 0.24; PCr = 5.71 ± 0.24; 
Hx = 6.19 ± 0.24; Urate = 6.9 ± 0.34; NAD = 8.55 ± 0.37; 
AMP = 9.61 ± 0.37; ADP= 11.89 ± 0.63 ; ATP= 14.9 ± 0.6. 
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Chromatograms of a standard and a muscle sample are presented in Appendix V. 
In the analysis conditions, the peak width was set at 0.5 min and peak sensitivity at 5%. In 
the muscle sample runs an unidentified peak eluted immediately after that of creatine and 
intefered with its baseline. Consequently, the creatine compounds (PCr and Cr) were 
quantified according to peak height instead of peak area. Since PCr could be analysed 
using peak height or peak area, the PCr concentration in selected standard and sample 
runs was calculated from both peak area and peak height. These were found to be similar. 
CHAPTER 4: 
THE EFFECTS OF PRIOR ORAL CREATINE 
SUPPLEMENTATION ON PERFORMANCE 
AND METABOLISM AFTER 7 DAYS OF 
INTERMITTENT SPRINT CYCLE 
TRAINING. 
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4.1 Study Design 
4.1.1 Subjects 
Thirteen male endurance trained cyclists ( with the ability to complete a 110 km cycle in 
under 3 hours) volunteered as subjects. Endurance trained subjects were chosen so that 
they had a baseline fitness level that was sufficient to withstand the overload of laboratory 
sprint training. The subjects were randomly, and in a double-blind fashion, assigned to an 
experimental group (those receiving a creatine supplement), or control group (those 
receiving a placebo). The nature and risks of the experimental procedures were explained 
(Appendix I), and written informed consent was obtained from the subjects (Appendix II). 
The study was approved by the Ethics and Research Committee of the University of Cape 
Town. 
4.1. 2 Experimental design 
The laboratory trial spanned 22 days. All subjects were familiarised with the performance 
tests and the training protocol during the week prior to the experimental trial. Initially, 
subjects ingested a loading dose of the creatine supplement or placebo for 7 days, after 
which they ingested a maintenance dose for the remainder of the trial ( see section 4. 1. 4). 
After supplement loading, subjects were required to do 3 exercise performance tests and a 
metabolic test. The metabolic test consisted of blood sampling during multiple sprint bouts 
in the laboratory (defined in more detail in section 4.1.6). The tests took place on 3 
different days, each separated by a day of rest. After the week of sprint training, the 
metabolic and performance tests were repeated in a similar manner (Figure 1). 
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FIGURE 1. Schematic representation of the experimental design. B, biopsy; T, sprint 
training session; r, rest day; PSPO, peak sustained power output test; WAT, 
Wingate anaerobic power test; 1-hr, 1-hr distance trial. 
An initial muscle biopsy was taken on the first day of the subject's supplementation week 
(prior to beginning supplementation), and a second biopsy was taken on the 7th day of 
supplementation. The final biopsy was taken on the 7th day of sprint training before the 
training bout. This was after a day of rest in order to avoid the influence of any acute 
effects of the last training session on the muscle sample (Figure 1). 
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4.1.3 Training Record 
Subjects were requested to maintain a consistent level of outdoor endurance training 
during the experimental trial. They recorded their training on a daily log sheet. In 
addition, subjects recorded their dietary intake for the three days prior to each biopsy, and 
were instructed to keep this as consistent as possible. 
4.1. 4 Supplementation 
The creatine monohydrate supplement (Ergomax, AMS Ltd, England) and placebo 
(glucose tablets that were supplied by AMS Ltd, England, and were shaped identically) 
were administered in a double-blind fashion. During the loading week, subjects ingested 5 
x 1 g colourless and odourless effervescent tablets 4 times per day for 7 days. This 
approximated a dose of 20 g of creatine per day. The tablets were taken dissolved in warm 
fluid at the 3 main mealtimes and before the daily training bout (in the event of a "rest day", 
the 4th dose of tablets was taken immediately before sleep). Times of ingestion and 
physical and psychological states (and any possible side-effects) were recorded daily on a 
log sheet. 
During the week of sprint training and until the last performance test, subjects ingested a 
maintenance dose of2 x 1 g of creatine monohydrate or placebo per day. 
4.1. 5 Intermittent sprint training 
Subjects reported to the laboratory on 6 consecutive days, and then once more following a 
day of rest for their sprint training. The training was performed on the Wingate Monark 
ergo meter and consisted of a short warm-up ( 10 min of light cycling), and 10 bouts of 10 s 
maximal sprint cycling with 140 s active recovery (no resistance) between bouts. The load 
55 
on the ergometer was set at 0.1 kilopond/kg body mass. This particular training protocol 
was chosen so that the work bouts elicited maximal use of the phosphagen and adenine 
nucleotide energy pathways, and the rest bouts facilitated almost complete resynthesis of 
high energy phosphates during recovery. It should be noted that the one week of training 
was not chosen to elicit a training adaptation, but rather to elicit a marked decrease in 
resting muscle total adenine nucleotide levels as previously shown using a similar protocol 
(Hellsten-Westing et al. , 1993b). 
Training took place at the same time every day, and subjects were permitted to drink water 
ad libitum. Heart-rate was monitored during training on each day via a Polar heart-rate 
monitor (Polar, Helsinki, Finland). Also, a subjective rating of perceived exertion was 
made by each subject at the end of each training session using a modified Borg scale with 
ratings from 6 to 20 (Appendix III) . Subjects maintained their usual outdoor endurance 
training during the week. 
4.1.6 Exercise performance and metabolic tests 
Before and after the week of intermittent sprint training, subjects were required to undergo 
three performance tests. These included a peak sustained power output test (PSPO), a 1-
hr distance trial, and a 30 s Wingate anaerobic test (WAT). The WAT and PSPO test were 
performed on the same day (PSPO first , WAT second) separated by 30 min of inactive 
recovery. During both tests, subjects were instructed to remain seated, and they were 
given strong verbal encouragement. During the 1-hr test, subjects were aware of the time 
elapsed since the start of the test, but were blinded to the distance covered until after the 
whole trial was completed. Subjects were permitted to drink water ad libitum during the 
tests. Details of these tests are described in Chapter 3. 
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In order to examine whether creatine loading prior to, and maintenance during sprint 
training had any effect on the metabolic response to intermittent sprint exercise, the first 
and last day of the week of sprint training were used as metabolic tests. Mixed venous 
blood samples were taken at rest; immediately after the 5th and 10th bout of exercise; and 
at 5, 10, 20, and 30 min during the recovery from exercise. Details of the blood sampling 
and analysis methods are described in Chapter 3. 
4.1. 7 Statistical analysis 
The results are expressed as means ± SEM, unless otherwise stated. Analyses were 
performed using the Statistica Analysis software package (Statsoft Inc., Tulsa, Oklahoma). 
A Student's t-Test for unpaired samples was employed when comparing the subject 
characteristics of each group. For the performance and muscle data, a two-way analysis of 
variance (ANOVA) with repeated measures was used to compare the main effect of group 
within each trial. The blood data was analysed using a three-way ANOV A with repeated 
measures, where the group means were compared within each trial and time point. Where 
significance was indicated a Tukey NSD post-hoc analysis for unequal sample size was 
performed. The relationship between creatine loading and other factors (such as fibre type 
and weekly training distance) was examined using a Pearson Product Moment Correlation 
Coefficient. The level of significance used to reject the null hypothesis was p < 0. 05 . 
4.2 Results 
After all analyses were completed, the investigators were unblinded. Seven subjects had 
taken the creatine supplement and 6 subjects had taken the placebo. Subject characteristics 
are presented in Table 3. The subjects' road endurance cycle training was consistent 
during the 2 weeks of the testing and laboratory training. 
TABLE 3. Subject Characteristics 
Age (yr) 
Height (cm) 
Mass pre-supplementation (kg) 
Mass post-supplementation (kg) 
Mass post-training (kg) 
Road training during supplement 
loading (km/d) 
Road training during supplement 
maintenance (km/d) 
Placebo Group 
24.3 ± 1.5 
177.3 ± 0.04 
72.4 ± 3.6 
73 .2 ± 3.7 * 
72.8 ± 3.7 
35.6 ± 4.5 
37.3 ± 7.3 
Creatine Group 
24.0 ± 2.6 
176.8 ± 0.04 
69.0 ± 4.3 
70.1 ± 4.4 * 
70.5 ± 4.4 
35.0 ± 6.9 
33.2 ± 4.0 
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Values are means± SEM. Placebo group, n = 6; Creatine group, n = 7. * Significantly different from pre-
supplementation. 
4. 2.1 Data collected at rest 
The muscle samples from 2 subjects were too small for accurate analysis, therefore the 
results of the muscle substrates and metabolites represent data from 5 subjects in the 
placebo group and 6 subjects in the creatine group. All muscle biopsies were taken at rest, 
thus results represent resting concentrations. 
a.) Creatine loading 
Prior to either placebo or creatine ingestion, the mean total creatine content (TCr) for each 
group was similar to previously reported levels (Harris et al., 1992; Harris et al., 1974). As 
shown in Figure 2, the oral creatine supplementation regimen of 20 g creatine monohydrate 
per day for 7 days significantly (p < 0.05) elevated skeletal muscle TCr by an average of 
21% (121 ± 4 mmol/kg dm to 147 ± 9 mmol/kg dm), while TCr levels in the placebo 
group remained unchanged (122 ± 4 mmol/kg dm to 125 ± 4 mmol/kg dm). The upper 
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limit of muscle creatine content after loading was 177 mmol/kg dm. Of the increase in the 
TCr pool, approximately 94% resulted from a rise in creatine content alone. When 
analysed separately, PCr and Cr did not change significantly (PCr for the placebo group 
pre: 74.1 ± 5.6, post: 70.5 ± 6.2; creatine group pre: 77.8 ± 5.3, post: 77.6 ± 3. 7mmol/kg 
dm) (Cr for the placebo group pre: 47.4 ± 1.9, post: 54.4 ± 6.5; creatine group pre: 45 .0 ± 
6.4, post: 69.3 ± 6.9 mmol/kg dm). 
Within the creatine supplemented group, the increase in TCr varied extensively between 
subjects (ranging from +8 .8 to +54 mmol/kg dm). Three subjects appeared to have very 
low creatine uptake(< 20mmol/kg dm), and one subject (No. 1) did not increase his TCr 
content above 120 mmol/kg dm (Figure 3). This variance in the extent of creatine uptake 
into the muscle was not related to the subjects' initial total creatine content (r = 0.09, NS). 
Also, the change in TCr did not correlate significantly with the subjects' weekly road 
training distance (r = -0.37, NS). In contrast, there was a highly significant correlation 
between the increase in muscle TCr and the percentage of Type IIB muscle fibres (r = 0.95, 
p < 0.005) (Figure 4). This relationship was specific to Type IIB fibres and did not hold 
for the sum of all Type II fibres (r = 0.42, NS). The percentage of Type IIB fibres did not 
correlate significantly with the initial (pre-supplementation) TCr content (r = 0.17, NS, n = 
11), but did correlate with the final (post-supplementation) TCr content (r = 0.89, p < 
0.05, n = 6). Percent fibre type and area of skeletal muscle fibres for each group are 
presented in Table 4. Creatine uptake did not correlate with either percent Type IIA fibres 
(r = -0.42, NS) nor percent Type I fibres (r = -0.45, NS) 
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TABLE 4. Percent fibre type(%) and area (µm) in skeletal muscle fibres of the placebo 
and creatine groups. 
Placebo Group Creatine Group 
Percent Type I 43 .3 ± 2.2 40.4 ± 3.2 
Percent Type IIA 26.3 ± 1.3 30.8±3.1 
Percent Type IIB 30.6±3.1 28.7±1.5 
Area Type I 5240 ± 315 4781 ± 116 
Area Type IIA 5332 ± 606 5331 ± 330 
Area Type IIB 5983 ± 665 5445 ± 302 
Values are means± SEM. 
During the week of creatine or placebo loading, there was a significant increase in body 
mass (p < 0.05) independent of the group. The mean increase in body mass was similar in 
both groups (placebo group: 1.2 kg; creatine group: 1.1 kg). However, the subject who 
showed the largest increase in mass (2.05 kg), also had the largest increase in TCr content 
( + 54 mmol/kg dm), although this relationship did not form a trend in all the subjects 
(r = -0.16, NS). Both groups' body mass was relatively unchanged following the 7 days of 
training (mean change in placebo group: - 0.4 kg; creatine group: + 0.4 kg) (Table 3). 
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FIGURE 2. Skeletal muscle total creatine content before (0 ) and after(~) 
supplementation with either 20 g of creatine monohydrate or placebo per day for 7 days. 
Values are means ± SEM. * Significantly different from before supplementation and 
placebo group (p < 0.05). 
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FIGURE 3. Skeletal muscle total creatine content (TCr) before ( o) and after ( •) 
supplementation with 20 g creatine monohydrate per day for 7 days, and after a 
maintenance dose of 2 g per day for 15 days (I) for each subject who had been randomised 
to the creatine group. 
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FIGURE 4. The relationship between the increase in skeletal muscle total creatine content 
(TCr) after supplementation with 20 g of creatine monohydrate per day for 7 days and the 







Placebo group Creatine group 
FIGURE 5. Skeletal muscle total creatine content before (D) and after(~) 6 days of sprint 
training during which subjects ingested 2 g of either creatine monohydrate or placebo per 
day. Subjects had ingested a loading dose of 20 g of creatine monohydrate or placebo per 
day for 7 days prior to sprint training. Values are means ± SEM. No significant difference 
from before training or between the groups. 
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As depicted in Figure 5, the creatine-loaded group showed a 12.3% decrease in TCr 
content from 147 ± 9 mmol/kg dm before the sprint training to 129 ± 5 mmol/kg dm after 
the training, despite ingesting a maintenance dose of creatine. Although this was a marked 
decrease, it was not quite statistically significant (p = 0.08). Due to this reduction 
however, the TCr content in the creatine group by the end of the training week was no 
longer significantly greater than TCr content in the placebo group. Muscle TCr 
concentrations of the placebo group were similar before and after training (125 ± 4 
mmol/kg dm to 130 ± 1 mmol/kg dm). 
The week of sprint training did not have a significant effect on muscle PCr levels ( creatine 
group : pre: 77.6 ± 3.7, post: 72.0 ±2.9; placebo group: pre: 70.5 ± 6.2, post: 74.7 ± 6.0 
mmol/kg dm). 
No ill effects of supplementation were noted. 
b.) Adenine nucleotides 
As represented in Figure 6 and Figure 7 respectively, the 6 days of sprint training resulted 
in a significant (p < 0.05) reduction in both skeletal muscle ATP content and the total 
adenine nucleotide pool (TAN = the sum of ATP and ADP) in both the creatine and 
placebo groups. AMP levels were below the detection limit of the analysis method ( < 1 
mmol/kg dm), and hence are not reported or included in TAN. Mean resting muscle ATP 
content fell from 24.1 ± 0.8 to 17.2 ± 0.5 mmol/kg dm in the creatine group, and from 26.5 
± 1. 1 to 18. 0 ± 0. 6 mmol/kg dm in the placebo group after the training. The percentage 
reduction in ATP content from before training was not different between the two groups 
(creatine group : 27.2 ± 4 %; placebo group: 30.0 ± 2 %). This finding was similar for the 
total adenine nucleotide pool which showed a 25 .1 ± 4 % reduction in the creatine group 
(27.3 ± 1.0 to 20.0 ± 0.4 mmol/kg dm), and a 27.6 ± 3 % reduction in the placebo group 
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(29.8 ± 1.4 to 20.9 ± 0.7 mmol/kg dm). Although the values were marginally lower after 
the sprint training, resting ADP concentrations were not statistically significantly different 
before and after the training or between the groups (creatine group pre: 3.2 ± 0.3 vs. post: 
2.8 ± 0.2; placebo group: pre: 3.3 ± 0.2 vs. post: 2.9 ± 0.2 mmol/kg dm). 
The loss in adenine nucleotides after training was not related to any fibre type composition 
in particular. More specifically, ATP loss did not correlate with percent Type I (r = 0.49, 
















Placebo group Creatine group 
FIGURE 6. Skeletal muscle adenosine 5'-triphosphate (ATP) concentration before (0) 
and after (~) 6 days of sprint training during which subjects ingested a maintenance dose of 
2 g of either creatine monohydrate or placebo per day. Subjects had ingested a loading 
dose of 20 g per day for the 7 days prior to sprint training. Values are means ± SEM. * 
Significantly different from before training (p < 0.05). 
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FIGURE 7. Skeletal muscle total adenine nucleotide (TAN= ATP+ ADP) concentration 
before (0) and after (~) 6 days of sprint training during which subjects ingested a 
maintenance dose of 2 g of either creatine monohydrate or placebo per day. Subjects had 
ingested a loading dose of 20 g per day for the 7 days prior to training. Values are means 
± SEM. * Significantly different from before training (p < 0.05) . 
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4. 2. 2 Data collected during exercise 
a.) Blood data 
The week of intermittent sprint training had a pronounced effect on the products of adenine 
nucleotide degradation measured in plasma samples. These samples were taken during 
exercise and recovery on days 1 (trial 1) and 7 (trial 2) of the sprint training. Both days 
were preceded by a rest day. 
During the 10 sprint bouts, plasma ammonia (NH3) concentration increased significantly in 
both groups, with peak values in excess of 200 µmol/1 in some subjects. Ammonia 
accumulation in trial 2 was significantly (p < 0.05) lower than trial 1 for both the creatine 
and placebo groups (Figure 8, see Appendix VI for numeric values). During the recovery 
period, the post-training concentrations were on average 27% and 25% lower than the pre-
training concentrations for the creatine and placebo groups respectively. In the creatine 
group the lower plasma NH3 accumulation in trial 2 was visually evident (see Figure 8) 
from before the 5th sprint bout (111 ± 12 µmol/1 in trial 2, vs. 142 ± 18 µmol/1 in trial 1), 
while the placebo groups' plasma NH3 levels in trial 2 were only different in the recovery 
period (i.e. after the 10th sprint bout). This subtle difference between the two groups was 
not sufficient to meet the level of statistical significance established for this study. Indeed, 
differences were only significant between trial 1 and 2 at 10 mins in the recovery from the 
training session for both groups. 
The training bouts also resulted in a significant increase in plasma hypoxanthine and urate 
concentrations which became evident towards the end of the sprint bouts and during 
recovery from the exercise. As was found for plasma ammonia concentration, both groups 
displayed significantly (p < 0.05) lower plasma hypoxanthine and urate levels after the 
week of training. (Figure 9 and Figure 10 respectively, see Appendices VII and VIII for 
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numeric values). The decreased plasma accumulation ofhypoxanthine was evident as early 
as the 5th sprint bout and remained lower throughout the recovery period. The training 
resulted in an average reduction in hypoxanthine levels that was similar between groups 
( creatine group - 2.4-fold lower; placebo group - 2.3-fold lower). Although the creatine 
group exhibited mean plasma hypoxanthine values that were up to 18% lower than that of 
the placebo group at any given time point both pre- and post-training, the individual 
variation rendered this difference statistically insignificant. 
The training-induced difference in plasma urate concentration was more delayed than that 
of either NH3 or hypoxanthine, and only became conspicuous at 10 mins in the recovery 
from exercise. The groups showed a comparable decrease in the extent of urate 
accumulation following training: by 30 mins of recovery from exercise, urate 
concentrations were on average 80% and 84% of the mean pre-training values at the same 
time point for the creatine and placebo groups respectively. 
Plasma lactate concentration increased significantly during the 10 sprint bouts. 
In contrast to the products of adenine nucleotide degradation, lactate accumulation was 
very similar between the two trials and the two groups. Also, there was less individual 
variance between the subjects. As can be seen in Figure 11 , plasma lactate concentration 
peaked approximately 5 mins post-exercise with values of up to 18.3 ± 1.1 mmol/1. 
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b.) Performance data 
The results of the performance tests are presented in Table 5. 
Peak sustained power output (PSPO) was significantly (p < 0.05) higher in the creatine 
group after training compared to the placebo group who remained comparatively 
unchanged. This change in PSPO in the creatine group represents only a 2.23% increase 
while PSPO decreased in the placebo group by 1.36%. The distance covered in the I-hour 
cycle test did not change significantly after the training and did not differ between the two 
groups. 
In the 3 0 s Wingate test, peak power; mean power; and peak cadence were all significantly 
increased after the training (p < 0.05, p < 0.01, p < 0.05 respectively). This improvement 
was similar in both groups. The 12% and 10% improvement in peak power of the placebo 
and creatine groups respectively may be almost completely accounted for in the increased 
peak pedal frequency (12% and 7% respectively). The placebo groups' fatigue rate 
increased from trial 1 to trial 2 by 3 7% ( from 20 ± 1. 9 to 2 7 ± 3. 6 W / s) in contrast to an 
increase of only 8% (from 19 ± 1.2 to 21 ± 3.1 W/s) in the creatine group. However, this 
difference was not significant (p = 0 .19). 
c.) Heart-rate and subjective evaluations 
In both groups, the heart-rate response during trial 1 and trial 2 was comparable before and 
after training (Figure 12). On average, subjects were exercising at up to 88 .3% (creatine 
group) and 88.7% (placebo group) of their age-predicted maximum heart-rate during the 
sprint bouts. 
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The subjective ratings of perceived exertion acquired at the end of each training session 
were not significantly different between the creatine and placebo groups during the 
training. Both groups found the exercise slightly easier towards the 5th day and ratings fell 
from 15 ± 1 units on the 1st day to 13 ± 1.4 units on the 7th day, and from 14.6 ± 0.7 to 
13.7 ± 0.6 units, for the placebo and creatine groups respectively over the whole week's 
training. This decrease was not statistically significant. 
Four of the seven subjects who ingested the creatine supplement (57%) made a special 
note in their logbooks that they felt "strong" or "good" during the later days for the 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The major findings of the present study which will be discussed below are that 1) the 
uptake of creatine into the muscle following oral creatine supplementation is related to the 
percentage of Type IIB muscle fibres; 2) muscle total creatine (TCr) content after 
supplement loading is not maintained during intermittent sprint training despite a 
maintenance dose of 2 g per day; 3) intermittent sprint training improves sprint 
performance, and has a significant effect on adenine nucleotide metabolism. 
4.3.1 Creatine loading 
In this study, oral creatine supplementation markedly increased creatine uptake into 
skeletal muscle, but the extent of this ranged from 8 mmol/kg dm to 54 mmol/kg dm. 
When interpreting these results, the possible effects of low subject numbers and relatively 
small changes in TCr in 50% of the subjetcs ought to be borne in mind. As far as the 
authors are aware, this is the first study to show that the extent of increase in TCr after 
creatine supplementation is linearly and positively related to the pecentage Type IIB muscle 
fibres. Since the individual variation in fibre type composition is considerable (in the 
present study the percentage of Type IIB fibres ranged from 19% to 40% ), this may also 
be an explanation for the previous findings of large variations in the individual responses to 
a similar creatine supplementation regimen (Greenhaff et al. , 1994a; Harris et al. , 1992; 
Lemon et al. , 1995A). 
There are a few possible reasons that may explain this phenomenon. The functions of PCr 
as an energy reservoir for the rapid re synthesis of ATP, and as a shuttle for high energy 
phosphates from the mitochondria to the myofibril, make PCr and creatine integrally 
related to adenine nucleotide (AN) metabolism. Considering that the regulation of AN 
metabolism varies between the fibre types (Dudley and Terjung, 1985a; Meyer et al., 1980; 
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Meyer and Terjung, 1979; Tullson et al. , 1990), it is likely that creatine and PCr levels are 
also regulated differently in different fibre types. In addition, it is probable that differences 
in AN metabolism are evident not only between Type I and Type II fibres in general, but 
more specifically between Type IIA and IIB fibres . Such differences have been shown 
between fast glycolytic and fast oxidative-glycolytic fibres in rats (Dudley and Terjung, 
1985a). In particular, fast glycolytic fibres displayed significantly greater ATP and PCr 
reduction and greater AMP dearninase activity, than fast oxidative-glycolytic fibres, in 
response to an electrical stimulus (5 Hz) in in situ rat muscle. As these differences were 
eliminated when blood flow was occluded, the authors concluded that differences between 
the fibres occured relative to the muscle fibre ' s functional capacity for aerobic metabolism. 
Thus, variance in the regulation of AN metabolism appears to be consistent with the 
metabolic profiles of Type I and Type IIA, and Type 11B fibres. Given that Type IIB fibres 
are maximally recruited only during very high-intensity exercise (Burke and Edgerton, 
1975; Vollestad et al. , 1984) in which the acceleration of energy production is fast, it is not 
surprising that 1) resting PCr content in Type II muscle fibres is significantly greater than in 
Type I muscle fibres (Edstrom et al. , 1982; Greenhaff et al. , 1994A; Tesch et al. , 1989), 
and 2) the extent of PCr degradation and utilisation rates are greater in Type II fibres 
during a 3 0 s treadmill sprint ( Greenhaff et al. , 1994 A). A higher muscle TCr content 
would make Type IIB fibres more suited to respond to maximal energy demands. Thus, 
the preferential increase in TCr in Type IIB fibres after supplementation may be a reflection 
of their greater capacity to accommodate a higher TCr content. A significant relationship 
was not found between the increase in TCr and either percentage Type IIA fibres, or the 
sum of the pecentage Type IIA and IIB fibres. These data suggest that the greater PCr 
content in Type II fibres found previously (Edstrom et al. , 1982; Tesch et al. , 1989; 
Greenhaff et al. , 1994A) was probably predorninanatly due to higher PCr content in Type 
11B fibres. 
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Although the percentage of Type IIB fibres correlated significantly with the change in TCr 
and the final (post-supplementation) TCr contents, it did not correlate with initial (pre-
supplementation) TCr levels. This suggests that the characteristic feature of Type IIB 
fibres that facilitates increases in TCr content with supplementation is likely to be 
predominantly related to a process of creatine uptake into the muscle fibre under conditions 
of high plasma creatine concentrations which is not evident under normal conditions, and 
to a lesser extent, the storage capacity of the muscle fibre . 
Other factors have been reported to be related to the variance in the extent of creatine 
"loading" . Greenhaff et al. (1994a) and Harris et al. (1992) found that the extent of 
creatine loading was dependent on an individual' s initial creatine content prior to 
supplementation. Those subjects with an initial TCr content of close to or less than 120 
mmol/kg dm showed the greatest increases in TCr with supplementation. Such a 
relationship was not evident in this study, although the subject numbers are small. Another 
variable identified as influencing the extent of creatine uptake into the muscle is exercise. 
Harris et al. (1992) showed that after supplementation the increase in TCr in 5 subjects 
who performed 1 hour of hard one-legged exercise per day was significantly greater in the 
exercised than the sedentary leg. In the present study, despite all subjects performing a 
substantial amount of road training (>230 km/week), not all subjects loaded substantially 
with creatine. The extent to which subjects loaded was not related to the amount of road 
training they performed per week (r =-0.65, NS). 
In this study the mean increase in muscle TCr of 21 % is in agreement with the 20%, 19% 
and 15% increases reported by Harris et al. (1992), Greenhaff et al. (1994b) and Greenhaff 
et al. (1994a) respectively after subjects followed a similar supplementation regimen. The 
maximum TCr content following loading was 177 mmol/kg dm. The high value was not 
due to a higher normal range for our laboratory, since the lowest TCr measured was 108 
mmol/kg dm. This result is comparable to the previously reported level of 183 mmol/kg 
dm in one subject who augmented his initial increase in TCr by one-legged hard exercise 
(Harris et al. , 1992). It appears that the physiological upper limit to creatine loading is 
higher than the previously suggested range of 150 to 160 mmol/kg dm (Greenhaff et al., 
1994a; Harris et al. , 1992) regardless of the the influence of exercise. In addition, this 
maximum value occurred in the subject with the highest percentage of Type IIB fibres. 
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The observation that 94% of the increase in TCr was in the form of creatine was notably 
greater than the - 80% found by Harris et al. (1992). Although these data are difficult to 
understand, it is possible that the lack of equilibrium between creatine and phosphocreatine 
is a function of the low subject response to creatine ingestion. Alternatively, this may be 
related to the state of relaxation of each subject prior to or during the muscle biopsy 
procedure. Isometric contraction of the quadriceps muscle prior to, or on insertion of the 
biopsy needle into the muscle, may have resulted in a decrease in the relative ratio of PCr : 
Cr in the muscle, and consequently the concentration of creatine in the muscle would have 
been higher than that in a truly rested state. 
In contrast with other studies (Balsom et al. , 1993 a; Greenhaff et al. , 1994a; Lemon et al. , 
1995A; Soderland et al. , 1994A; Stroud et al. , 1994; Viruet al. , 1993) the change in body 
mass in the creatine supplemented group (mean + 1.1 kg) was not statistically significantly 
different from the placebo group. This is probably due to a comparable gain in mass found 
in the placebo group (mean+ 1.2 kg), and the variance in the response to creatine 
supplementation. The mechanism by which an increase in body mass accompanies creatine 
loading is not clear. Two theories proposed suggest that with increased TCr concentration 
there is 1) an increase in total body water content; and 2) an increase in contractile protein 
synthesis (Balsom et al. , 1993a). Although the latter theory has indirect experimental 
support (lngwall et al. , 1972; lngwall et al. , 1974; Meyer et al. , 1986; Sipila et al. , 1981 ;), 
other data is not supportive (Fry and Morales, 1980). Although the time of day subjects 
were tested was controlled, it is proposed that the level of hydration in regularly exercising 
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athletes may not be consistent and thus may confound the results of studies in which small, 
consistent gains in body mass from an experimental intervention are expected. 
It is apparent from this and other studies that creatine supplementation does not guarantee 
that muscle TCr stores will increase significantly in all individuals. The effect of creatine 
supplementation on exercise performance has been widely studied in recent years, but 
conflicting results have placed its ergogenic effect in some doubt. One possible reason for 
these conflicting results could be the varying degree to which individuals load with 
creatine. This issue has not been sufficiently examined previously as many of these studies 
did not quantify skeletal muscle TCr before and after supplementation. It is suggested that 
any ergogenic effect of creatine supplementation depends on the extent of this loading 
which in turn is highly associated with an individual' s percentage of fast glycolytic muscle 
fibres. It is important that factors which influence creatine uptake into the muscle are taken 
into consideration before creatine is administered to athletes at random. 
4.3.2 Creatine maintenance 
Following a loading regimen of creatine supplement, it has been suggested that a 
maintenance dose of 2 g of creatine per day should be sufficient to maintain muscle TCr at 
a high, "loaded" level (Greenhaff, 1995). Although this particular dosage has not been 
experimentally tested, it is based on the daily turnover rate of creatine for an individual 
with an average total muscle creatine content of 120 to 130 mmol/kg dm. (Harris et al. , 
1974; Harris et al. , 1992). In the present study, however, the 2 g per day maintenance 
dose for 11 days failed to keep TCr significantly elevated, since after the maintenance 
period, the creatine group no longer had a significantly greater TCr content than the 
placebo group. This may be due to the unusually high stress that was placed on the high-
energy phosphate system during the repeated days of high-intensity training. Also, Crim et 
al. ( 197 6) proposed that creatinine excretion does not necessarily match creatine synthesis, 
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but rather creatinine is excreted at a constant fraction (- 0.016) of the body creatine pool. 
It is possible that if the total body creatine pool increases with creatine loading, the fraction 
ofthis pool excreted as creatinine will also increase. In this study, a theoretical calculation 
of the amount of the total creatine pool that will be excreted per day (Appendix XI) shows 
that the placebo group is likely to excrete 2.3 g, while the creatine group is likely to excrete 
2.9 g. In the placebo group the 2.3 g is higher than the 2 g previously described due to the 
assumption that trained athletes in this study have a greater muscle mass than an average 
70 kg male. The lack of change in resting TCr content in the placebo group with training, 
implies that daily turnover of the creatine pool was maintained sufficiently by dietary intake 
and endogenous synthesis of creatine. However, in the creatine group, the increased TCr 
pool size resulted in an increase in its turnover of at most 1 g per day. The maintenance 
dose of 2 g per day ought to have been sufficient to sustain this increased turnover, but this 
was not the case, and TCr in the creatine group decreased with training. Thus, the 
excessive sprint training appeared to result in a "draining" of muscle creatine in the loaded, 
but not the unloaded state. This suggests that the minimum or normal average level of 
muscle TCr is more tightly regulated than an overloaded level. 
It is possible, that measurement of creatinine excretion during and following creatine 
loading may indicate that the currently advised maintenance dose of creatine may need to 
be re-evaluated. 
4.3.3 Intermittent sprint exercise and training 
An acute decrease in intramuscular ATP (Cheetham et al. , 1986; Gaitanos et al. , 1993; 
Tullson et al. , 1995) and TAN concentration (Sahlin and Broberg, 1990; Tullson et al. 
1995) has been commonly observed at completion of a bout of high-intensity exercise. 
During high-intensity intermittent exercise where the rate of ATP hydrolysis exceeds 
resynthesis, the accumulating ADP is converted to ATP and AMP. Subsequently, AMP is 
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deaminated to IMP with the release of ammonia (NH3) to the plasma. Further degradation 
of IMP results in the loss of purines from the muscle cell as indicated by plasma 
accumulation ofhypoxanthine and urate. In this study, the high plasma accumulation of 
NH3, hypoxanthine and urate during and after the high-intensity intermittent training bouts 
verified that there was indeed an imbalance between ATP hydrolysis and resynthesis rates 
and consequently AN degradation. High plasma concentrations of ammonia, hypoxanthine 
and urate have been previously demonstrated after bouts of sprint exercise (Greenhaff et 
al., 1994b; Hellsten-Westing, 1993a). 
The week of intermittent sprint training elicited a significant decrease in resting TAN and 
ATP stores in the muscle. The change in ATP and TAN concentrations were not due to an 
acute exercise response as the biopsy sample was taken 48 hours after the last training 
session. The reduction of between 28% and 32% was slightly greater, but comparable to 
that (18% to 23%) described previously (Green et al. , 1987; Hellsten-Westing et al., 
1993b; Stathis et al. , 1994). 
Since TAN and ATP contents were still reduced 2 days after the sprint training ended, it 
would appear that the consecutive days of training resulted in a sustained environment of 
enhanced IMP catabolism in which the repeated loss of purines from the muscle to the 
plasma was in excess of purine salvage and de nova synthesis. This would be particularly 
evident in Type II muscle fibres which exhibit a greater degree of AN degradation (Dudley 
and Terjung, 1985a; Meyer et al. , 1980; Meyer and Terjung, 1979; Tullson et al. , 1990) 
and slower rates of de nova ATP synthesis than Type I fibres (Tullson et al. , 1988), 
although we did not measure this. It has also been proposed that high-intensity training 
results in a "down-regulation" in muscle adenine nucleotide content (Hellsten-Westing et 
al. , 1993b; Stathis et al. , 1994) which may result in an earlier acceleration of ATP 
resynthesis or an amplification of the signal due to the comparatively lower concentration 
of ATP at the onset of exercise. 
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The present study and previous reports (Green et al. , 1987; Hellsten-Westing et al. , 1993b; 
Stathis et al. , 1994) of decreased levels of adenine nucelotides are in conflict with other 
studies which have suggested that high-intensity training 1) does not cause any change in 
resting muscle AN levels (Boobis et al. , 1983A; Nevill et al. , 1989; Thorstensson et al. , 
1975) or 2) causes an increase in AN levels (Eriksson et al. , 1975; Houston and Thomson, 
1977). These conflicting results may be best explained by differences in the training 
protocols used in each study. Those studies that showed a decrease in AN content 
following training used training protocols that were extremely strenuous and consisted 
exclusively of repetitions of one exercise type at maximal intensity. This implies that there 
may be a threshold intensity of metabolic stress above which significant AN loss is likely to 
occur. From this study it is evident that significant AN degradation will occur after 
consecutive days of intermittent sprint exercise at an intensity that results in a peak plasma 
lactate level of about 18 mmol/1. Similarly, such a threshold was observed in a study on 
horses in which significant AN degradation only occurred above a blood lactate 
concentration of 15 mmol/1 (Sewell and Harris, 1992). These authors proposed that there 
was a critical pH below which there may have been a substantial decrease in ADP 
rephosphorylation by PCr which resulted in a marked increase in ADP degradation. 
Alternatively it may be related to the marked increase in AMP deaminase activity which is 
evident at and below a muscle pH of 6.6 units (Dudley and Terjung, 1985b). This is also 
indirect support for the theory that AN loss is a result of a compromised capacity to replete 
ATP and thus AN. 
An hypothesis of this study was that increased muscle TCr content could decrease this 
effect by improving ADP rephosphorylation kinetics. However, this study failed to show 
that increased muscle TCr content attenuates a decrease in ATP and TAN content. This 
failure may be related to the fact that by the end of the training week the creatine group no 
longer had a significantly greater TCr content compared to the placebo group. Thus, it is 
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possible that if the TCr content in the creatine group had remained significantly greater 
than that in the placebo group, the extent of AN loss with training may have been different 
between the two groups. This question therefore remains unanswered. 
Plasma accumulation of metabolites measured in this study during and after the intermittent 
sprint bouts were comparable to previously reported levels for ammonia (Greenhaff et al. , 
1994bt hypoxanthine (Bangsbo et al. , 1992; Hellsten-Westing et al. , 1993a); urate 
(Hellsten-Westing et al. , 1993a); and lactate (Greenhaff et al. , 1994; Withers et al. , 1986). 
The intermittent sprint training resulted in a decreased accumulation of AN degradation 
products in the plasma ( ammonia, hypoxanthine and urate) during and in the recovery from 
exercise when comparing the first and last training session. This finding is supported by 
previous work (Hellsten-Westing et al., 1993a; Snow et al. , 1992; Stathis et al., 1994). A 
lower concentration of ammonia, hypoxanthine and urate in the plasma may be due to one, 
or a combination of the following: 1) a decrease in the production of that compound in the 
muscle; 2) a decrease in the efflux of that compound from the muscle (which may relate to 
increased salvage or reuse of the compound in the muscle); and 3) an increase in the 
removal of that compound from the plasma. 
A mechanism for the decreased accumulation of these compounds cannot be deduced 
directly from the measurements made in this study. However, the observation that there 
was a greater training effect on plasma hypoxanthine and urate concentrations than on 
plasma ammonia concentration suggests that the most pronounced effect occurred after 
AMP deamination in the AN catabolic pathway. Two means by which plasma 
hypoxanthine accumulation may be reduced after AMP deamination are firstly, that there is 
increased IMP reamination via the purine nucleotide cycle (PNC) after training (although 
this is unlikely as the activity of the reamination limb of the PNC is very low during intense 
exercise) (Meyer and Terjung, 1980; Tullson and Terjung, 1991); and secondly, that there 
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is increased muscular hypoxanthine salvage to IMP. The latter theory is indirectly 
supported by Hellsten-Westing et al. (1993a) who reported an increase in the activity of the 
enzyme responsible for this conversion (hypoxanthine phosphoribosyl transferase, HPRT) 
after 6 weeks of high-intensity training. Also, after training, an improvement in the 
clearance of AN degradation products from the plasma may have been greater for 
hypoxanthine and urate in comparison to ammonia. 
Alternatively, lower plasma accumulation of the compounds may be a result of decreased 
AN degradation due to training. Stathis et al. (1994) reported that the magnitude of 
decrease in ATP during a sprint bout was reduced by 52% after sprint training despite 
subjects having a comparatively lower resting ATP concentration after the training. This, 
and the present study' s findings may be related to a decrease in AMP deaminase activity 
which has been shown to occur after high-intensity training (Hellsten-Westing, 1993a; 
Tullson and Terjung, 1991), and may be the mechanism for the "down-regulation" 
previously discussed. 
Considering that the half-life of protein is approximately 10 days, it is unlikely that the 7 
days of training would provide sufficient time to increase enzyme content or activity 
significantly. It is possible that the metabolic alteration evident after the training may 
rather be due to a reorganisation of the localisation of enzymes. This may manifest in an 
increased efficiency of the PCr-Cr shuttle, as it relies on the compartmentalisation of 
compounds and enzymes. 
Another possibility is that sprint training increases the capacity of oxygen-independent 
glycolysis at maximal workloads, as has been previously proposed by Nevill et al. (1989) 
and Linossier et al. (1993). This would imply that the contribution of oxygen-independent 
glycolysis to energy production is greater at maximal workloads, thus partially relieving the 
stress on AN metabolism, and attenuating the loss of purines to the plasma. Higher plasma 
85 
concentrations of lactate, and increased activity of PFK and LOH after sprint training have 
been reported as evidence for greater energy production from oxygen-independent 
glycolysis (Linossier et al. , 1993). In contrast however, in this study plasma lactate 
concentration during the metabolic tests before and after training was similar, and thus the 
contribution of oxygen-independent glycolysis to energy production appeared to be 
unaltered by the 7 days of training. Considering that increases in the activities of glycolytic 
enzymes such as PFK and LOH have as yet only been demonstrated after more than 5 
weeks of training (Linnossier et al. , 1993; Roberts et al, 1982), it is possible that an 
adaptation in this system may take longer than 7 days to become evident. 
A limitation of this study was that the exact amount of work done during each metabolic 
test (i.e. day 1 or day 7 of the sprint training) was not quantified. Based on the similarity 
of plasma lactate data and heart-rate data between day 1 and day 7, it is highly unlikely that 
the amount of work performed on the 7th day was less than that on the 1st day of training. 
Considering this, the metabolic effects of training that have been discussed previously are 
based on the premise that the work performed during the 1st and 7th day of training was 
( at least) the same. It is possible, since the training resulted in an increase in peak cadence 
in the Wingate test, that cadence during the 10 s sprints was greater on the 7th compared 
to the 1st day of training. Cadence is a variable that contributes to the amount of work 
performed. If the amount of work performed on the 7th day was greater than that on the 
1st day, then the metabolic changes that were observed are even more remarkable. 
Although, at this point, mechanisms for reduced accumulation of AN degradation products 
in the plasma after sprint training need further investigation, it is noteworthy that in this 
study, the training had a pronounced effect on metabolism in only 7 days. Most training 
studies only measure adaptations after 5 to 6 weeks. 
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4. 3. 4 fuercise performance 
Improvements in high-intensity short duration performance with high-intensity short 
duration training have been previously documented (Houston and Thomson, 1977; Nielsen 
et al. , 1994; Nevill et al. , 1989; Stathis et al. , 1994). The 10 to 12% increase in peak 
power in the Wingate test is comparable to the 12% improvement reported by Nevill et al. 
(1989) in a 30 s treadmill sprint test but less than the 25% increase in a 30 s Wingate after 
7 weeks of sprint training (Linossier et al., 1993). The mechanisms responsible for this 
improved performance are not clear. The most obvious, is that motor coordination 
improved (by familiarity) with training such that the subjects are able to increase cadence. 
Peak power is a function of both peak cadence and the workload applied (which in this test 
was constant), thus if peak cadence increases peak power will increase accordingly. 
Alternatively, the improved performance in the 30 s sprint may be related to the decreased 
plasma accumulation of ammonia and other purines after training. The latter is associated 
with less or delayed perturbation of cellular ATP homeostasis, and less accumulation of 
ADP, Pi, and Ir which are known to be potential fatiguing agents (Cooke and Pate, 1990; 
Sahlin, 1992). Also, it has been suggested that exercise-induced hyperammonemia may be 
involved in the mechanism of muscle fatigue by its effect on the central nervous system ( e.g 
motor incoordination) (Banister and Cameron, 1990); and thus the comparatively lower 
plasma NH3 after training may have contributed to a delayed onset of muscular fatigue. 
In addition, performance was improved despite subjects having a reduced resting muscle 
concentrations of ATP and TAN. It is unknown whether performance would have been 
improved to a greater extent had ATP and TAN levels not been so reduced. 
The lack of ergogenic effect of creatine supplementation on Wingate test performance may 
be related to two factors. Firstly, there was a low response of subjects to creatine 
ingestion, and secondly that the mainteanace dose was ineffective such that TCr in the 
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creatine group was not in fact higher than that in the placebo group by the end of training. 
In contrast, creatine loading with training had a significant ergogenic effect on peak 
sustained power output (PSPO). This may not be a highly reproducible finding considering 
that the improvement in PSPO in the creatine supplemented group was only 2.2% ( + 8 W) 
and the placebo groups' PSPO dropped by 1.4% (- 5 W). If this finding is not due to 
variability however, then it is particularly interesting considering that the average duration 
of a PSPO test is 8 to 10 mins - which is noticably longer (up to 8 mins) than any 
previously reported exercise that has been shown to improve with creatine supplementation 
(Balsom et al. , 1993; Birch et al. , 1994; Greenhaff et al. , 1993; Lemon et al., 1995A;; Viru 
et al., 1993). This may be related to the observation that 57% of the creatine group made 
subjective evaluations of feeling "strong" or "good" during the training week in contrast to 
only one subject in the placebo group making a similar evaluation. This raises the 
interesting questions as to whether creatine: 1) has an acute ergogenic effect during high-
intensity exercise soon after creatine ingestion; or 2) improves the capacity for sprint 
training and therefore the adaptation to it. 
In contrast to the effect on the Wingate test parameters and PSPO, the week ofhigh-
intensity training did not increase the 1-hr distance performance significantly (although 
both groups increased the mean distance covered). This supports the theory of training 
specificity - that is, in order to improve high-intensity endurance performance, one must 
perform sustained high-intensity training. There is evidence that sustained high-intensity 
training improves endurance performance (Acevedo and Goldfarb, 1989). In the latter 
study, long distance runners improved their 10 km race time after 8 weeks of increased 
training intensity. The observation that glycolytic metabolism was comparatively 
unaffected by high-intensity training in the present study ( compared to the pronounced 
effect on AN metabolism) is a possible explanation for the finding that 1-hr performance 
was unchanged. However, an increase of 1 km (as was shown in the placebo group), 
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although not statistically significant, may have become so with larger subject numbers, and 
would be of practical significance to performance in the field. 
4.4 Conclusions 
This study has shown that oral creatine supplementation results in an increase in muscle 
TCr content, the extent of which is strongly related to an individual' s percentage of Type 
IIB fibres. A maintenance dose of 2 g of creatine per day is ineffective in maintaining TCr 
at a significantly higher level during a week of intermittent sprint training. Consequently, it 
is still unknown whether a significantly elevated muscle TCr content can attenuate the 
decrease in skeletal muscle ATP and TAN content after consecutive days of strenuous 
sprint training. Whether this decrease is a result of the stress of the training, or an 
adaptation to the training cannot be concluded from this study. The training did, however, 
result in an attenuation in the accumulation of plasma products of adenine nucleotide 
degradation (NH3, hypoxanthine and urate) during and after exercise. Also, performance 
in a 30 s Wingate cycle test improved significantly after training, although the training did 
not improve I-hr cycle distance performance. The ergogenic effect of creatine 
supplementation during sprint training on performance indices cannot be effectively 
evaluated from this study since TCr content did not remain significantly elevated during the 
week of training. In addition, the relatively low subject numbers and marginal changes in 




· In recent years the practise of oral creatine supplementation has received considerable 
interest from both scientists and athletes. Although earlier studies showed that creatine 
supplementation resulted in increased muscle TCr levels and had an ergogenic effect on 
short duration high-intensity exercise, more recent reports showing varied responses in the 
change in TCr after supplementation and no improvements in exercise performance have 
made the topic controversial. This study complements current literature confirming that 
oral creatine supplementation does in fact increase muscle TCr content, but emphasises 
that the extent of this increase is related to an individual's percentage of Type IIB fibres. 
This has important practical implications. An ergogenic effect of creatine supplementation 
should not be guarenteed to any athlete without prior examination of factors which may 
influence the efficacy of the athlete' s "loading", in particular their muscle fibre 
composition. 
For those individuals who respond positively to creatine supplementation, it is important 
to know the most physiologically effective, and cost effective ways to maintain high TCr 
stores over a longer duration of time. In this study the maintenance dose of 2 g of creatine 
per day that has been suggested previously was ineffective in maintaining TCr at a 
significantly higher level. This may have been due to (in part) the concurrent week of 
high-intensity sprint training, or perhaps another unidentified mechanism. This issue 
certainly warrants further investigation. 
In support of previous work (Hellsten-Westing et al. 1993b; Stathis et al. , 1994), it has 
been shown that consecutive days of intermittent sprint training results in a significant 
reduction in resting muscle TAN and ATP content. Although evidence for an alteration in 
AN metabolism during exercise was found, the exact mechanism for the reduction in 
resting stores cannot be concluded from this study. Possible theories are that the decrease 
is a result of the extreme metabolic stress of the sprint, or that it is an adaptation to the 
training. A more extensive examination of the breakdown compounds of AN metabolism 
and related enzyme activities is needed to determine the sites of adaptation and to provide 
support for such theories. 
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The question of whether the performance improvements after sprint training would have 
been even greater had muscle ATP or TAN concentration not been so reduced also 
remains to be answered. The hypothesis that an elevation in muscle TCr content through 
supplementation may attenuate the decrease in skeletal muscle ATP and TAN content 
after sprint training could not be resolved due to the ineffective maintenance of TCr levels 
during the training. This ineffective maintenance of TCr also prevented a reliable and valid 
evaluation of the ergogenic effect of increased TCr stores during intermittent sprint 
training. Both of these theoretical concepts should be resolved easily once an effective 
maintenance dose of creatine has been determined for these training conditions. 
In addition to addressing novel theories, this study has provided support for established 
current literature in certain areas. These include the findings that sprint training 1) results 
in an attenuation in the accumulation of plasma products of adenine nucleotide 
degradation (NH3, hypoxanthine and urate) during and after exercise; 2) improves sprint 
performance; and 3) does not improve high-intensity endurance performance. 
In conclusion, this thesis has addressed a variety of current and controversial issues. 
Although some of the findings add to the established literature considerably, there are 
questions that have been left unanswered, and new theories have been raised which 
warrant further investigation. 
It is recommended that future research include 1) the study of the efficacy of a 
maintenance dose of creatine without concurrent sprint training, and 2) the measurement 
of urinary creatinine excretion during this period to establish whether excretion is 
increased due to an elevated muscle TCr content. Once an effective maintenance dose of 
creatine has been established, a study similar to the present one ought to be done in order 
to validate whether an increase in TCr has an ergogenic effect on performance with sprint 
training. Finally, the mechanism for AN loss with intensive sprint training should certainly 
be examined by the measurement of AN, their breakdown products, and enzyme activities. 
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APPENDIX I: An example of the Subject Information Sheet. 
This is some information regarding the laboratory trial you have volunteered to participate 
in. If you do not understand anything, please ask for further explanation. The muscle 
biopsy and blood sampling procedures will be explained to you in detail verbally. They 
will be performed by qualified medical personnel under sterile conditions. 
The Tests: 
• Peak sustained power output (PSPO) on a lab bike, where the workload is increased in 
stages until exhaustion ... .. lasts from 10 -15 min 
• Wingate test on a lab bike, - an all-out maximal sprint for 30 seconds 
• I -hr trial on your own bike supported on a cyclosimulator in the laboratory, cover as 
much distance as possible in 1 hour (self-selected workloads) 
Before each test: 
• have a rest day or a light training session the previous day 
• eat at least 4 hours before the test, and try to keep the meal and time of meal similar for 
all tests 
• don't ingest any stimulants (eg caffeine), or alcohol 
• take your last supplement tablet at least 8 hours before the test 
• remember your pedals (and spanner) for the Wingate, PSPO, and training sessions; and 
your bicycle for the I-hr trial 
• check that your back tyre's inner tube has no previous punctures for the I-hr test 
The Familiarisation Week: 
• to get you familiar with the tests and equipment 
The Supplement Loading Week: 
• you have either the creatine supplement or a placebo 
• take 5 tablets at each of your 3 main mealtimes, and 5 tablets just before your training 
session ( on your rest day, take the last 5 tablets just before going to sleep) ... .. .ie. you 
are taking 20 tablets / day 
• dissolve the tablets in warm / hot water 
• record time of ingestion on your log sheet 
• any tablets not taken must be returned to the investigators 
The Supplement Maintenance Week: 
• take 2 tablets every day 
The Sprint Training Week: 
• training will be in the laboratory using the lab bike 
• for 7 days, at the same time each day 
• on day I and day 7 blood samples will be taken from a forearm vein 
• IO x IO s sprints at a fixed workload, with 140 s recovery 
• total time about 3 0 min 
Training Record: 
• record your training for 7 days after the first familiarisation I-hr trial 
• keep your training for the following week as similar to this as possible, and record 
agam 
103 
• during the training week try to maintain your usual endurance riding, even if it is very 
low intensity 
Dietary Record: 
• maintain the same dietary intake for the 3 days prior to your second and third biopsies 
that you ingested for the 3 days prior to the I st biopsy 
APPENDIX II: An example of the Informed Consent. 
I, , hereby consent to participate in a research project at the 
MRC/UCT Bioenergetics of Exercise Research Unit, Department of Physiology, 
University of Cape Town Medical School. 
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I understand that the project will involve multiple laboratory visits over a 3-week period. 
On these occasions I will be required to undergo a variety of exercise tests including 3 
peak sustained power output tests, 3 one-hour cycling trials, and three 30 s Wingate tests. 
I understand that I will be required to complete one week of high-intensity training 
involving multiple 10 s sprints each day. In addition, I understand that on two occasions 
blood samples will be taken during and after the exercsie tests. 
Furthermore, I understand that I will be required to have muscle biopsies on 3 separate 
occasions. I realise that this procedure is invasive and requires a sample of muscle to be 
taken from my leg by a qualified medical doctor using local anaesthetic and normal sterile 
procedures. 
I fully understand the risks associated with this project which have been outlined in the 
information sheet and explained to me. I understand that I am free to withdraw from the 
study at any time should I so choose. 
Signed ---------- Date --------
Investigator _______ _ 
Supervisor ---------
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APPENDIX ID: Rating of Perceived Exertion (Modified Borg Scale). 
Rating of Perceived Exertion 
6 
7 fairly light 
8 




13 very hard 
14 
15 very, very hard 
16 





APPENDIX IV: A chromatogram of both a standard solution (A) and an extracted 
plasma sample solution (B) from the analysis of plasma orate and 
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muscle sample solution (B) from the analysis of adenine nucleotides 
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APPENDIX VI: Plasma ammonia accumulation (µmol/1) on the 1st and 7th day 
of sprint training for both the placebo and creatine groups. 
Placebo group Creatine group 
1st day 7th day 1st day 7th day 
Rest 43 .2 ± 5 54.6 ± 13 .7 41.2 ± 4 48.8 ± 5 
Sprint bout 5 143 .8 ± 26 139.0 ± 33 141.5 ± 18 111.2 ± 12 
Sprint bout 10 198.0 ± 25 186.0 ± 24 194.5 ± 16 135.7 ± 22 
5 min recovery 181.8 ± 29 133.4 ± 10 164.7 ± 12 120.2 ± 17 
10 min recovery 144.5 ± 22 90.4 ± 14 * 134.0 ± 12 100.7 ± 17 * 
20 min recovery 97.6 ± 19 65.0 ± 4 93 .8 ± 11 76.0 ± 12 
3 0 min recovery 76.2 ± 6 57.4 ± 5 79.3 ± 9 67.5 ± 12 
Values are means± SEM. * Significantly different from 1st day of sprint training. No difference 
between the groups. 
APPENDIX VII: Plasma hypoxanthine accumulation (µmol/1) on the 1st and 7th 
day of sprint training for both the placebo and creatine groups. 
Placebo group Creatine group 
1st day 7th day 1st day 7th day 
Rest 1.7 ± 0.3 2.4 ± 1.4 1.0 ± 0.2 1.4 ± 0.4 
Sprint bout 5 23 .3 ± 4.4 7.8 ± 4.2 * 19.2 ± 2.7 4.2 ± 1.3 * 
Sprint bout 10 57.9 ± 8.9 23 .7 ± 8.2 * 48.5 ± 6.9 19.4 ± 4.8 * 
5 min recovery 60.2 ± 9.0 25 .9 ± 7.6 * 49.4±4.1 22.1 ± 5.7 * 
10 min recovery 56.5 ± 9.9 28 .6 ± 8.2 * 52.8 ± 4.2 23 .3 ± 6.2 * 
20 min recovery 50.8 ± 10.1 21.2 ± 7.5 * 52.0 ± 2.4 21.2±7.2 * 
30 min recovery 41.4 ± 9.2 14.9 ± 5.3 * 44.4 ± 2.8 17.7±7.1 * 
Values are means± SEM. * Significantly different from 1st day of sprint training. No difference 
between the groups. 
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APPENDIX VIll: Plasma urate accumulation (µmol/1) on the 1st and 7th day of 
sprint training for both the placebo and creatine groups. 
Placebo group Creatine group 
1st day 7th day 1st day 7th day 
Rest 283 .7 ± 23 306.1 ± 18 327.0 ± 20 329.1±31 
Sprint bout 5 299.1 ± 20 305.5 ± 18 330.0 ± 18 332.1 ± 32 
Sprint bout 10 331.9 ± 22 312.4 ± 16 311.9 ± 49 362.2 ± 50 
5 min recovery 328.0 ± 22 307.7±17 359.8 ± 23 331.6 ± 24 
10 min recovery 387.9 ± 40 330.0 ± 19 * 386.8 ± 14 327.9 ± 13 * 
20 min recovery 424.2 ± 35 355.5 ± 20 * 427.8 ± 20 359.5 ± 19 * 
30 min recovery 438.0 ± 40 370.1 ±23 * 459.2 ± 16 368.6 ± 13 * 
Values are means± SEM. * Significantly different from 1st day of sprint training. No difference 
between the groups. 
APPENDIX IX: Plasma lactate accumulation (mmol/1) on the 1st and 7th day of 
sprint training for both the placebo and creatine groups. 
Placebo group Creatine group 
1st day 7th day 1st day 7th day 
Rest 1.8 ± 0.1 1.8 ± 0.3 1.9 ± 0.2 1.9±0.1 
Sprint bout 5 12.7 ± 1.4 13.2 ±0.6 15.2 ± 0.6 14.8 ± 0.6 
Sprint bout 10 16.2 ± 1.3 17.0±1.2 17.8 ± 0.7 18.3 ± 1.1 
5 min recovery 15 .0 ± 1.8 16.5±1.4 18.1±0.5 18.2 ± 1.3 
10 min recovery 14.2±2.1 14.3±1.4 16.0 ± 0.9 17.0±1.4 
20 min recovery 10.6 ± 1.9 10.2 ± 1.5 13 .3 ± 1.0 13 .6 ± 1.8 
30 min recovery 7.3 ± 1.5 7.7 ± 1.3 10.8 ±0.9 10.4 ± 1.7 
Values are means± SEM. No difference between 1st day and 7th day of sprint training, or 
between the groups. 
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APPENDIX X: Peak heart-rate (bpm) after each 10 s sprint bout on the 1st and 
7th day of sprint training for both the placebo and creatine groups. 
Placebo group Creatine group 
1st day 7th day 1st day 7th day 
Bout 1 163 .8 ± 7 160.2 ± 9 163.3 ± 6 165.8 ± 4 
Bout 2 168.0 ± 7 159.4 ± 6 164.3 ± 6 163.8 ± 6 
Bout 3 169.0 ± 6 162.6 ± 3 164.7 ± 6 165.3 ± 5 
Bout4 168.3 ± 5 164.0 ± 3 167.8 ± 5 164.8 ± 6 
Bout 5 169.4 ± 4 168.0 ± 3 166.8 ± 6 165.7 ± 5 
Bout 6 164.8 ± 3 163 .8 ± 3 163.3 ± 3 166.5 ± 5 
Bout 7 167.0 ± 4 165.8 ± 4 162.3 ± 4 165.0 ± 5 
Bout 8 165.2 ± 3 164.8 ± 3 163.2 ± 4 165.2 ± 5 
Bout 9 164.6 ± 3 166.2 ± 3 163.2 ± 4 163.8 ± 5 
Bout 10 167.2 ± 3 164.6 ± 4 162.8 ± 4 164.3 ± 4 
Values are means± SEM. No difference between 1st day and 7th day of sprint training, or 
between the groups. 
APPENDIX XI: Theoretical calculation of the amount of the total creatine pool 
that is excreted as creatinine in both a normal subject and a 
creatine-loaded subject. 
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According to Crim et al. (1976), 1.6% of the total creatine pool is lost as creatinine per 
day. Based on the fact that 95% of the total creatine pool in in the skeletal muscle, this 
calculation makes the assumption that the total creatine pool is equivalent to the skeletal 
muscle creatine pool. 
a) In normal unloaded muscle (placebo group) 
TCr = 120 mmol/kg dm 
= 24 mmol/kg wwt 
= 960 mmol 
Amount excreted = 0.016 x 960 
= 15 .4 mmol per day 
2.3 g per day = 
(If 58% of a 70 kg trained male is muscle 
mass, then muscle weight = 40 kg) 
(molecular mass of creatine = 150) 
b) In creatine loaded muscle (creatine group) 
TCr = 150 mmol/kg dm 
= 30 mmol/kg wwt 
= 1200 mmol 
Amount excreted = 0.016 x 1200 
= 19.2 mmols per day 
(If 58% of a 70 kg trained male is muscle 
mass, then muscle weight = 40 kg) 
= 2.9 g per day (molecular mass of creatine = 150) 
